CDK4
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00267 | T806 | Sugiyama | SUPT5H SPT5 SPT5H | MYGsQtPLQDGsRtPHyGsQtPLHDGsRtPAQsGAWDPNNP |
| O14497 | S363 | Sugiyama | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | AAAAAAASGGAQQRsHHAPMsPGssGGGGQPLARtPQPssP |
| O15151 | S314 | EPSD|PSP | MDM4 MDMX | TDVEVTSEDEWQCTECKKFNsPSKRYCFRCWALRKDWYSDC |
| O43791 | S6 | EPSD|PSP | SPOP | _______________MsRVPsPPPPAEMSSGPVAESWCYTQ |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60292 | S158 | Sugiyama | SIPA1L3 KIAA0545 SPAL3 | FHRLSRRRsKDVEFQDGWPRsPGRAFLPLRHRsssEItLSE |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04179 | S106 | EPSD|PSP | SOD2 | PALKFNGGGHINHSIFWTNLsPNGGGEPKGELLEAIKRDFG |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05187 | S177 | Sugiyama | ALPP PLAP | RAKKAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADVP |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P06400 | S249 | SIGNOR|PSP | RB1 | LsPPMLLKEPYKTAVIPINGsPRtPRRGQNRSARIAKQLEN |
| P06400 | S608 | EPSD|PSP | RB1 | sACPLNLPLQNNHtAADMyLsPVRsPKKKGSTTRVNstANA |
| P06400 | S612 | EPSD|PSP | RB1 | LNLPLQNNHtAADMyLsPVRsPKKKGSTTRVNstANAETQA |
| P06400 | S780 | SIGNOR|iPTMNet|EPSD|PSP | RB1 | FMQRLKtNILQyAstRPPtLsPIPHIPRsPyKFPssPLRIP |
| P06400 | S788 | SIGNOR|iPTMNet|EPSD|PSP | RB1 | ILQyAstRPPtLsPIPHIPRsPyKFPssPLRIPGGNIyIsP |
| P06400 | S795 | SIGNOR|iPTMNet|EPSD|PSP | RB1 | RPPtLsPIPHIPRsPyKFPssPLRIPGGNIyIsPLKsPYKI |
| P06400 | S807 | EPSD|PSP | RB1 | RsPyKFPssPLRIPGGNIyIsPLKsPYKIsEGLPtPtKMtP |
| P06400 | S811 | SIGNOR|EPSD|PSP | RB1 | KFPssPLRIPGGNIyIsPLKsPYKIsEGLPtPtKMtPRSRI |
| P06400 | T252 | EPSD|PSP | RB1 | PMLLKEPYKTAVIPINGsPRtPRRGQNRSARIAKQLENDTR |
| P06400 | T356 | SIGNOR|iPTMNet|EPSD|PSP | RB1 | FLDHDKTLQTDsIDsFEtQRtPRKsNLDEEVNVIPPHtPVR |
| P06400 | T373 | EPSD|PSP | RB1 | tQRtPRKsNLDEEVNVIPPHtPVRTVMNTIQQLMMILNSAS |
| P06400 | T5 | SIGNOR|iPTMNet | RB1 | ________________MPPKtPRKTAATAAAAAAEPPAPPP |
| P06400 | T826 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | RB1 | IsPLKsPYKIsEGLPtPtKMtPRSRILVSIGEsFGtsEKFQ |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P07814 | S886 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPEAKVLFD |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P09923 | S174 | Sugiyama | ALPI | RAKQAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMP |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11802 | S28 | Sugiyama | CDK4 | PVAEIGVGAyGTVYKARDPHsGHFVALKSVRVPNGGGGGGG |
| P13051 | S12 | SIGNOR | UNG DGU UNG1 UNG15 | _________MIGQKtLysFFsPsPARKRHAPsPEPAVQGtG |
| P13051 | S14 | SIGNOR | UNG DGU UNG1 UNG15 | _______MIGQKtLysFFsPsPARKRHAPsPEPAVQGtGVA |
| P13051 | S23 | SIGNOR | UNG DGU UNG1 UNG15 | GQKtLysFFsPsPARKRHAPsPEPAVQGtGVAGVPEESGDA |
| P13051 | T60 | SIGNOR | UNG DGU UNG1 UNG15 | SGDAAAIPAKKAPAGQEEPGtPPssPLsAEQLDRIQRNKAA |
| P14866 | S101 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | GAAGGGGGGENyDDPHKtPAsPVVHIRGLIDGVVEADLVEA |
| P15923 | S139 | EPSD|PSP | TCF3 BHLHB21 E2A ITF1 | GLTQAGFLSGELALNSPGPLsPsGMKGTSQYYPSYsGssRR |
| P15923 | S154 | GPS6 | TCF3 BHLHB21 E2A ITF1 | SPGPLsPsGMKGTSQYYPSYsGssRRRAADGSLDTQPKKVR |
| P15923 | S245 | EPSD|PSP | TCF3 BHLHB21 E2A ITF1 | AELWsPPGQAGFGPMLGGGSsPLPLPPGSGPVGSSGSSSTF |
| P15923 | S48 | GPS6 | TCF3 BHLHB21 E2A ITF1 | LPVTNGKGRPAsLAGAQFGGsGLEDRPssGSWGSGDQSSSS |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17480 | S484 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | UBTF UBF UBF1 | KAQSERKPGGEREERGKLPEsPKRAEEIWQQSVIGDYLARF |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P19484 | S114 | PSP | TFEB BHLHE35 | EYLsEtYGNKFAAHIsPAQGsPKPPPAAsPGVRAGHVLSss |
| P19484 | S142 | PSP | TFEB BHLHE35 | sPGVRAGHVLSssAGNsAPNsPMAMLHIGsNPERELDDVID |
| P19484 | S467 | PSP | TFEB BHLHE35 | SDPLLstMsPEAsKAssRRssFsMEEGDVL___________ |
| P19484 | T331 | PSP | TFEB BHLHE35 | QLWLRIQELEMQARVHGLPttsPsGMNMAELAQQVVKQELP |
| P19532 | S246 | PSP | TFE3 BHLHE33 | QPLPAPEAAHTTGPTGSAPNsPMALLTIGSSSEKEIDDVID |
| P21333 | S1459 | PSP | FLNA FLN FLN1 | KVPVHDVTDASKVKCsGPGLsPGMVRANLPQsFQVDTSKAG |
| P21333 | S2152 | PSP | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P24385 | S41 | Sugiyama | CCND1 BCL1 PRAD1 | NLLNDRVLRAMLKAEETCAPsVsYFKCVQKEVLPSMRKIVA |
| P25205 | T722 | Sugiyama | MCM3 | GDsyDPyDFsDtEEEMPQVHtPKTADsQEtKEsQKVELsES |
| P25786 | S14 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQGSA |
| P26358 | S127 | EPSD|PSP | DNMT1 AIM CXXC9 DNMT | LENGNQARSEARRVGMADANsPPKPLSKPRTPRRsKsDGEA |
| P26358 | S954 | EPSD|PSP | DNMT1 AIM CXXC9 DNMT | RVGDGVYLPPEAFTFNIKLssPVKRPRKEPVDEDLyPEHyR |
| P27824 | S583 | Sugiyama | CANX | VsQEEEDRKPKAEEDEILNRsPRNRKPRRE___________ |
| P28749 | S640 | GPS6|ELM|iPTMNet|EPSD|PSP | RBL1 | PRVKEVRTDSGSLRRDMQPLsPISVHERYSsPtAGSAKRRL |
| P28749 | S650 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | RBL1 | GSLRRDMQPLsPISVHERYSsPtAGSAKRRLFGEDPPKEML |
| P28749 | S964 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL1 | SFALKYDLANQDHMMDAPPLsPFPHIKQQPGsPRRISQQHS |
| P28749 | S975 | GPS6|ELM|iPTMNet|EPSD|PSP | RBL1 | DHMMDAPPLsPFPHIKQQPGsPRRISQQHSIYIsPHKNGSG |
| P28749 | T369 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL1 | ANVEYNLQQHFEKKRSFAPstPLTGRRYLREKEAVItPVAS |
| P29692 | S133 | Sugiyama | EEF1D EF1D | NVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPAEDDE |
| P30281 | S133 | Sugiyama | CCND3 | LRETtPLtIEKLCIYtDHAVsPRQLRDWEVLVLGKLKWDLA |
| P30281 | S273 | Sugiyama | CCND3 | ESLREASQTSssPAPKAPRGsssQGPsQtstPtDVtAIHL_ |
| P30281 | S275 | Sugiyama | CCND3 | LREASQTSssPAPKAPRGsssQGPsQtstPtDVtAIHL___ |
| P30281 | S279 | Sugiyama | CCND3 | SQTSssPAPKAPRGsssQGPsQtstPtDVtAIHL_______ |
| P30281 | S282 | Sugiyama | CCND3 | SssPAPKAPRGsssQGPsQtstPtDVtAIHL__________ |
| P30281 | S43 | Sugiyama | CCND3 | GDQRVLQSLLRLEERyVPRAsyFQCVQREIKPHMRKMLAYW |
| P30281 | T117 | Sugiyama | CCND3 | AQLQLLGAVCMLLASKLRETtPLtIEKLCIYtDHAVsPRQL |
| P30281 | T120 | Sugiyama | CCND3 | QLLGAVCMLLASKLRETtPLtIEKLCIYtDHAVsPRQLRDW |
| P30281 | T128 | Sugiyama | CCND3 | LLASKLRETtPLtIEKLCIYtDHAVsPRQLRDWEVLVLGKL |
| P30281 | T281 | Sugiyama | CCND3 | TSssPAPKAPRGsssQGPsQtstPtDVtAIHL_________ |
| P30281 | T283 | Sugiyama | CCND3 | ssPAPKAPRGsssQGPsQtstPtDVtAIHL___________ |
| P30281 | T288 | Sugiyama | CCND3 | KAPRGsssQGPsQtstPtDVtAIHL________________ |
| P30281 | Y44 | Sugiyama | CCND3 | DQRVLQSLLRLEERyVPRAsyFQCVQREIKPHMRKMLAYWM |
| P30304 | S40 | SIGNOR|PSP | CDC25A | PPASQPVVKALFGASAAGGLsPVTNLTVTMDQLQGLGSDyE |
| P30304 | S88 | SIGNOR | CDC25A | NSNLQRMGsSEstDsGFCLDsPGPLDSKENLENPMRRIHsL |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P35998 | T193 | Sugiyama | PSMC2 MSS1 | TYSDVGGCKEQIEKLREVVEtPLLHPERFVNLGIEPPKGVL |
| P38398 | S632 | SIGNOR|EPSD|PSP | BRCA1 RNF53 | RRKSSTRHIHALELVVSRNLsPPNCTELQIDSCSSSEEIKK |
| P38936 | S130 | PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | HVDLsLSCTLVPRsGEQAEGsPGGPGDSQGRKRRQtsMTDF |
| P38936 | S98 | PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | LPtGPRRGRDELGGGRRPGtsPALLQGTAEEDHVDLsLSCT |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43694 | S105 | SIGNOR|EPSD|PSP | GATA4 | GSPGWSQAGADGAAYTPPPVsPRFSFPGTTGSLAAAAAAAA |
| P46108 | S41 | Sugiyama | CRK | QEAVALLQGQRHGVFLVRDsstsPGDyVLSVSENSRVSHYI |
| P46937 | T119 | Sugiyama | YAP1 YAP65 | PEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQLGAVsP |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49815 | S1217 | SIGNOR|PSP | TSC2 TSC4 | ILVRRPTGNTSWLMSLENPLsPFSSDINNMPLQELSNALMA |
| P49815 | S1452 | SIGNOR|PSP | TSC2 TSC4 | ASGEDSRGQPEGPLPsssPRsPsGLRPRGYtIsDsAPsRRG |
| P50552 | T76 | Sugiyama | VASP | PDQQVVINCAIVRGVKYNQAtPNFHQWRDARQVWGLNFGSK |
| P51991 | S358 | Sugiyama | HNRNPA3 HNRPA3 | QQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55072 | S664 | PSP | VCP HEL-220 HEL-S-70 | yIPLPDEKSRVAILKANLRKsPVAKDVDLEFLAKMTNGFSG |
| P55072 | T509 | PSP | VCP HEL-220 HEL-S-70 | LQELVQyPVEHPDKFLKFGMtPSKGVLFYGPPGCGKTLLAK |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62750 | S43 | Sugiyama | RPL23A | KAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPRK |
| P62750 | T42 | Sugiyama | RPL23A | LKAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPR |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P84022 | S204 | SIGNOR|iPTMNet|EPSD|PSP | SMAD3 MADH3 | YLSEDGETSDHQMNHSMDAGsPNLsPNPMsPAHNNLDLQPV |
| P84022 | S208 | SIGNOR|iPTMNet|EPSD|PSP | SMAD3 MADH3 | DGETSDHQMNHSMDAGsPNLsPNPMsPAHNNLDLQPVTYCE |
| P84022 | S213 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SMAD3 MADH3 | DHQMNHSMDAGsPNLsPNPMsPAHNNLDLQPVTYCEPAFWC |
| P84022 | T179 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SMAD3 MADH3 | SIPENTNFPAGIEPQSNIPEtPPPGYLSEDGETSDHQMNHS |
| P84022 | T8 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SMAD3 MADH3 | _____________MSsILPFtPPIVKRLLGWKKGEQNGQEE |
| Q04637 | S1231 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | tEDRDRGRDAVKREAALPPVsPLKAALsEEELEKKsKAIIE |
| Q06830 | T90 | SIGNOR | PRDX1 PAGA PAGB TDPX2 | NCQVIGASVDSHFCHLAWVNtPKKQGGLGPMNIPLVSDPKR |
| Q08050 | S35 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | RLPLPVQNAPSETSEEEPKRsPAQQESNQAEASKEVAESNS |
| Q08050 | S4 | SIGNOR|EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | _________________MKTsPRRPLILKRRRLPLPVQNAP |
| Q08050 | S451 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | APLSSAGPGKEEKLLFGEGFsPLLPVQTIKEEEIQPGEEMP |
| Q08050 | S489 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | EMPHLARPIKVEsPPLEEWPsPAPSFKEEssHsWEDssQsP |
| Q08050 | S508 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | PsPAPSFKEEssHsWEDssQsPtPRPKKSYSGLRsPTRCVS |
| Q08050 | S522 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | WEDssQsPtPRPKKSYSGLRsPTRCVSEMLVIQHRERRERS |
| Q08050 | S704 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | LIsVPFGNssPsDIDVPKPGsPEPQVsGLAANRsLtEGLVL |
| Q08050 | T510 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | PAPSFKEEssHsWEDssQsPtPRPKKSYSGLRsPTRCVSEM |
| Q08050 | T600 | EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | DSSDPASQLSYSQEVGGPFKtPIKETLPISStPsKSVLPRt |
| Q08050 | T611 | SIGNOR|EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | SQEVGGPFKtPIKETLPISStPsKSVLPRtPEsWRLtPPAK |
| Q08050 | T620 | SIGNOR|EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | tPIKETLPISStPsKSVLPRtPEsWRLtPPAKVGGLDFsPV |
| Q08050 | T627 | SIGNOR|EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | PISStPsKSVLPRtPEsWRLtPPAKVGGLDFsPVQTSQGAS |
| Q08999 | S1035 | GPS6|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | KQIKTFAMKYSQANMDAPPLsPYPFVRtGsPRRIQLSQNHP |
| Q08999 | S672 | GPS6|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | DTGGLGRsItsPTtLyDRYssPPAStTRRRLFVENDsPsDG |
| Q08999 | T401 | GPS6|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | VQMKNILQQHFDKSKALRIStPLTGVRyIKENsPCVtPVST |
| Q12778 | S249 | EPSD|PSP | FOXO1 FKHR FOXO1A | EGTGKssWWMLNPEGGKSGKsPRRRAAsMDNNSKFAKSRSR |
| Q13200 | S16 | Sugiyama | PSMD2 TRAP2 | _____MEEGGRDKAPVQPQQsPAAAPGGtDEKPsGKERRDA |
| Q13242 | S211 | Sugiyama | SRSF9 SFRS9 SRP30C | GYsRsRSGsRGRDsPyQsRGsPHyFsPFRPy__________ |
| Q13242 | S216 | Sugiyama | SRSF9 SFRS9 SRP30C | RSGsRGRDsPyQsRGsPHyFsPFRPy_______________ |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13573 | S232 | Sugiyama | SNW1 SKIIP SKIP | FKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQEWKIPPCIS |
| Q13761 | S356 | SIGNOR|EPSD|PSP | RUNX3 AML2 CBFA3 PEBP2A3 | TSSGSYQFSMVAGSSSGGDRsPTRMLASCTSSAASVAAGNL |
| Q13950 | S465 | PSP | RUNX2 AML3 CBFA1 OSF2 PEBP2A | LYYGTSsGSYQFPMVPGGDRsPSRMLPPCTTTSNGSTLLNP |
| Q14106 | S254 | SIGNOR|PSP | TOB2 KIAA1663 TOB4 TROB2 | SLSMHSLNFITANPAPQSQLsPNAKEFVYNGGGSPSLFFDA |
| Q14157 | S416 | Sugiyama | UBAP2L KIAA0144 NICE4 | tQsPsLVQYDLKNPsDsAVHsPFtKRQAFtPsstMMEVFLQ |
| Q14247 | S117 | Sugiyama | CTTN EMS1 | KsAVGHEyQSKLsKHCsQVDsVRGFGGKFGVQMDRVDQsAV |
| Q14814 | S110 | SIGNOR|EPSD|PSP | MEF2D | KKGFNGCDsPEPDGEDsLEQsPLLEDKyRRAsEELDGLFRR |
| Q14814 | S98 | SIGNOR|EPSD|PSP | MEF2D | SRTNADIIETLRKKGFNGCDsPEPDGEDsLEQsPLLEDKyR |
| Q14980 | S1757 | Sugiyama | NUMA1 NMP22 NUMA | ITSKLPRtQPDGtsVPGEPAsPIsQRLPPKVEsLEsLyFtP |
| Q15154 | S69 | Sugiyama | PCM1 | KKKFGVESDKRVTNDISPESsPGVGRRRTKTPHTFPHSRYM |
| Q15642 | T302 | Sugiyama | TRIP10 CIP4 STOT STP | VEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRSRTKRWP |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q6P1L8 | S49 | Sugiyama | MRPL14 MRPL32 RPML32 | LSAIQKMTRVRVVDNSALGNsPyHRAPRCIHVYKKNGVGKV |
| Q6PKG0 | S627 | Sugiyama | LARP1 KIAA0731 LARP | FLFDEEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVt |
| Q6PKG0 | S774 | Sugiyama | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q8IZL8 | S477 | SIGNOR|EPSD|PSP | PELP1 HMX3 MNAR | ALLTHLLSDISPPADALKLRsPRGsPDGsLQtGKPSAPKKL |
| Q8IZL8 | S991 | SIGNOR | PELP1 HMX3 MNAR | EVEEGAPPPPTLPPALPPPEsPPKVQPEPEPEPGLLLEVEE |
| Q8NFG4 | S571 | PSP | FLCN BHD | KFWMTGLSKTYKSHLMstVRsPTASESRN____________ |
| Q8NFG4 | S62 | PSP | FLCN BHD | GEQAEEEEGGIQMNSRMRAHsPAEGAsVEsssPGPKKSDMC |
| Q8NFG4 | S73 | PSP | FLCN BHD | QMNSRMRAHsPAEGAsVEsssPGPKKSDMCEGCRSLAAGHP |
| Q92830 | S372 | SIGNOR|PSP | KAT2A GCN5 GCN5L2 | ILTHFPKFLSMLEEEIYGANsPIWESGFTMPPSEGTQLVPR |
| Q92830 | T272 | SIGNOR|PSP | KAT2A GCN5 GCN5L2 | QTMFELSKMFLLCLNYWKLEtPAQFRQRSQAEDVATYKVNY |
| Q92879 | S302 | SIGNOR|EPSD|PSP | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | NALTTSSSPLSVLTSSGSsPsSSSSNSVNPIASLGALQTLA |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96FS4 | T64 | Sugiyama | SIPA1 SPA1 | RPVRGPLLRsGsDAGEARPPtPAsPRARAHsHEEAsRPAAT |
| Q96KS0 | S130 | EPSD|PSP | EGLN2 EIT6 | QGARPEAPKRKWAEDGGDAPsPsKRPWARQENQEAEREGGM |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q9BQA1 | S264 | EPSD|PSP | WDR77 MEP50 WD45 HKMT1069 Nbla10071 | STSCVLSSAVHSQCVTGLVFsPHSVPFLASLSEDCSLAVLD |
| Q9BQA1 | S306 | EPSD|PSP | WDR77 MEP50 WD45 HKMT1069 Nbla10071 | SLSELFRSQAHRDFVRDATWsPLNHSLLTTVGWDHQVVHHV |
| Q9BQA1 | T5 | EPSD|PSP | WDR77 MEP50 WD45 HKMT1069 Nbla10071 | ________________MRKEtPPPLVPPAAREWNLPPNAPA |
| Q9BR84 | S197 | Sugiyama | ZNF559 | KTHTQEKPYKCSDCEKGLPSssHLRECVRIYGGERPYTHKE |
| Q9BR84 | S198 | Sugiyama | ZNF559 | THTQEKPYKCSDCEKGLPSssHLRECVRIYGGERPYTHKEY |
| Q9BX95 | S112 | Sugiyama | SGPP1 SPP1 | GLAAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLF |
| Q9BX95 | T114 | Sugiyama | SGPP1 SPP1 | AAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLFCF |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9NS23 | S207 | SIGNOR | RASSF1 RDA32 | PsLQDARRGPGRGTSVRRRtsFYLPKDAVKHLHVLSRTRAR |
| Q9NS64 | S98 | PSP | RPRM | CNLLIKSEGMINFLVKDRRPsKEVEAVVVGPY_________ |
| Q9NYF8 | S290 | Sugiyama | BCLAF1 BTF KIAA0164 | ERsGsGsVGNGssRysPsQNsPIHHIPsRRsPAKtIAPQNA |
| Q9NZB2 | T991 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | PLQVVSVGGPARGRPRGVIstPVIRTFGRGGRYYGRGYKNQ |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S2694 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQSSs |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
| Q9Y5U2 | S146 | Sugiyama | TSSC4 | LAPsGRsPVEGLGRAHRsPAsPRVPPVPDYVAHPERWTKYS |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle, Mitotic | R-HSA-69278 | 3.421352e-08 | 7.466 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.448693e-08 | 7.073 | 1 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.998167e-06 | 5.155 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.877404e-05 | 4.726 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.058844e-05 | 4.392 | 1 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.263435e-05 | 4.203 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.838031e-05 | 4.106 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.085091e-04 | 3.965 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.172915e-04 | 3.931 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.698326e-04 | 3.770 | 1 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.103936e-04 | 3.677 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.765619e-04 | 3.424 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 7.623987e-04 | 3.118 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.426903e-04 | 3.129 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.278900e-04 | 3.138 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.773085e-04 | 3.057 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.080158e-03 | 2.967 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.144891e-03 | 2.941 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.144891e-03 | 2.941 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.340599e-03 | 2.873 | 1 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.410023e-03 | 2.851 | 0 | 0 |
| Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | R-HSA-210746 | 1.831537e-03 | 2.737 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.992025e-03 | 2.701 | 1 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.170700e-03 | 2.663 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.304941e-03 | 2.637 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.332329e-03 | 2.632 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.671257e-03 | 2.573 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.792958e-03 | 2.554 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.718485e-03 | 2.430 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.050371e-03 | 2.393 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.976253e-03 | 2.401 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.154349e-03 | 2.381 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.619190e-03 | 2.335 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.535930e-03 | 2.343 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.938257e-03 | 2.306 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.154194e-03 | 2.288 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 5.882474e-03 | 2.230 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 5.882474e-03 | 2.230 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.834870e-03 | 2.234 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.607988e-03 | 2.180 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.593860e-03 | 2.181 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.688600e-03 | 2.175 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.997495e-03 | 2.155 | 1 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 7.604513e-03 | 2.119 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 7.604513e-03 | 2.119 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.714750e-03 | 2.113 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.261815e-03 | 2.139 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 7.870379e-03 | 2.104 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.340413e-03 | 2.079 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 9.457333e-03 | 2.024 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.035757e-02 | 1.985 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 9.589059e-03 | 2.018 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.011243e-02 | 1.995 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.089316e-02 | 1.963 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.089316e-02 | 1.963 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.042024e-02 | 1.982 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.159565e-02 | 1.936 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.267588e-02 | 1.897 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.346255e-02 | 1.871 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.346636e-02 | 1.871 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.388971e-02 | 1.857 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.469674e-02 | 1.833 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.488580e-02 | 1.827 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.960020e-02 | 1.708 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.960020e-02 | 1.708 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.960020e-02 | 1.708 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.745915e-02 | 1.758 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.855784e-02 | 1.731 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.855784e-02 | 1.731 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.945965e-02 | 1.711 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.673000e-02 | 1.777 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.965393e-02 | 1.707 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.965393e-02 | 1.707 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.976526e-02 | 1.704 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.977906e-02 | 1.704 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.052134e-02 | 1.688 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.120633e-02 | 1.674 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 2.185418e-02 | 1.660 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 2.185418e-02 | 1.660 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.202924e-02 | 1.657 | 1 | 0 |
| Circadian clock | R-HSA-9909396 | 2.313883e-02 | 1.636 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.332694e-02 | 1.632 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.459079e-02 | 1.609 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.459079e-02 | 1.609 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.459079e-02 | 1.609 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.459079e-02 | 1.609 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.765348e-02 | 1.558 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.765348e-02 | 1.558 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.734389e-02 | 1.563 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.687931e-02 | 1.571 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.895713e-02 | 1.538 | 1 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.958879e-02 | 1.529 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.209693e-02 | 1.494 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.073896e-02 | 1.512 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.060559e-02 | 1.514 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.219797e-02 | 1.492 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.981807e-02 | 1.526 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.248889e-02 | 1.488 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.344363e-02 | 1.476 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.347275e-02 | 1.475 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.514805e-02 | 1.454 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.715410e-02 | 1.430 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.845624e-02 | 1.415 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.845624e-02 | 1.415 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.642178e-02 | 1.439 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.679855e-02 | 1.434 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.811289e-02 | 1.419 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.845624e-02 | 1.415 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.574100e-02 | 1.447 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.013118e-02 | 1.397 | 1 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.083960e-02 | 1.389 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.160117e-02 | 1.381 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.279412e-02 | 1.369 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.570278e-02 | 1.340 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.557328e-02 | 1.341 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.415760e-02 | 1.355 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.741824e-02 | 1.324 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.557470e-02 | 1.341 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.812288e-02 | 1.318 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.812288e-02 | 1.318 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.812288e-02 | 1.318 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.867390e-02 | 1.313 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 5.476968e-02 | 1.261 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 5.476968e-02 | 1.261 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 5.476968e-02 | 1.261 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.998834e-02 | 1.222 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.400739e-02 | 1.268 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.450477e-02 | 1.264 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.498186e-02 | 1.260 | 1 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.232551e-02 | 1.281 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.138157e-02 | 1.212 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.138157e-02 | 1.212 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.138157e-02 | 1.212 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.158750e-02 | 1.211 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.498186e-02 | 1.260 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.400739e-02 | 1.268 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.110969e-02 | 1.214 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.991363e-02 | 1.302 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.947856e-02 | 1.226 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.498186e-02 | 1.260 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.533065e-02 | 1.257 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.674479e-02 | 1.246 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.110969e-02 | 1.214 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.998834e-02 | 1.222 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.674479e-02 | 1.246 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.299444e-02 | 1.276 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.788141e-02 | 1.237 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.788141e-02 | 1.237 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.274936e-02 | 1.202 | 1 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.296434e-02 | 1.201 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 6.296434e-02 | 1.201 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.811759e-02 | 1.167 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.811759e-02 | 1.167 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.130862e-02 | 1.147 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.255961e-02 | 1.139 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.597673e-02 | 1.181 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.623623e-02 | 1.179 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.465662e-02 | 1.127 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.255961e-02 | 1.139 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.723904e-02 | 1.172 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.190093e-02 | 1.143 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.327481e-02 | 1.135 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.930289e-02 | 1.159 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.190093e-02 | 1.143 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.715692e-02 | 1.173 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.811759e-02 | 1.167 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 7.255961e-02 | 1.139 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.839573e-02 | 1.165 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.552133e-02 | 1.122 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.552133e-02 | 1.122 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 7.557198e-02 | 1.122 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 7.557198e-02 | 1.122 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.557198e-02 | 1.122 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 7.557198e-02 | 1.122 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 7.557198e-02 | 1.122 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 7.659810e-02 | 1.116 | 1 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 7.659810e-02 | 1.116 | 1 | 1 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.065428e-01 | 0.972 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.065428e-01 | 0.972 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.065428e-01 | 0.972 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.065428e-01 | 0.972 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.065428e-01 | 0.972 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 1.554830e-01 | 0.808 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 1.554830e-01 | 0.808 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 1.554830e-01 | 0.808 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 1.554830e-01 | 0.808 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 1.554830e-01 | 0.808 | 0 | 0 |
| Defective SLC9A9 causes autism 16 (AUTS16) | R-HSA-5619052 | 1.554830e-01 | 0.808 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 1.554830e-01 | 0.808 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.554830e-01 | 0.808 | 0 | 0 |
| Defective OPLAH causes OPLAHD | R-HSA-5578998 | 2.017453e-01 | 0.695 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 2.017453e-01 | 0.695 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 2.017453e-01 | 0.695 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 2.017453e-01 | 0.695 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 9.226899e-02 | 1.035 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 1.099110e-01 | 0.959 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.099110e-01 | 0.959 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.454761e-01 | 0.610 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.454761e-01 | 0.610 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 2.454761e-01 | 0.610 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 2.454761e-01 | 0.610 | 0 | 0 |
| Defective GSS causes GSS deficiency | R-HSA-5579006 | 2.454761e-01 | 0.610 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.454761e-01 | 0.610 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 1.283446e-01 | 0.892 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.283446e-01 | 0.892 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.283446e-01 | 0.892 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.283446e-01 | 0.892 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.283446e-01 | 0.892 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.474304e-01 | 0.831 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.868136e-01 | 0.542 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.868136e-01 | 0.542 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.868136e-01 | 0.542 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.868136e-01 | 0.542 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.868136e-01 | 0.542 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.868136e-01 | 0.542 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.868136e-01 | 0.542 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.670420e-01 | 0.777 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.670420e-01 | 0.777 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.166951e-01 | 0.933 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.166951e-01 | 0.933 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.166951e-01 | 0.933 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 1.870646e-01 | 0.728 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 1.870646e-01 | 0.728 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.870646e-01 | 0.728 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.870646e-01 | 0.728 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.870646e-01 | 0.728 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.870646e-01 | 0.728 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 3.258887e-01 | 0.487 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.258887e-01 | 0.487 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.258887e-01 | 0.487 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 3.258887e-01 | 0.487 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 3.258887e-01 | 0.487 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.289955e-01 | 0.889 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 2.073945e-01 | 0.683 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.073945e-01 | 0.683 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.073945e-01 | 0.683 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 1.417305e-01 | 0.849 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.548632e-01 | 0.810 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.548632e-01 | 0.810 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.548632e-01 | 0.810 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.279382e-01 | 0.642 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.279382e-01 | 0.642 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.279382e-01 | 0.642 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.279382e-01 | 0.642 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.279382e-01 | 0.642 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.279382e-01 | 0.642 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.279382e-01 | 0.642 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.279382e-01 | 0.642 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.628252e-01 | 0.440 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.628252e-01 | 0.440 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.628252e-01 | 0.440 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.628252e-01 | 0.440 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 3.628252e-01 | 0.440 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.181299e-01 | 0.928 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.683570e-01 | 0.774 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.683570e-01 | 0.774 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.683570e-01 | 0.774 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.683570e-01 | 0.774 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.486114e-01 | 0.604 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.486114e-01 | 0.604 | 1 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.486114e-01 | 0.604 | 1 | 1 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.837548e-02 | 1.007 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.821757e-01 | 0.740 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.375488e-01 | 0.862 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.210356e-02 | 1.086 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.210356e-02 | 1.086 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.210356e-02 | 1.086 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.962835e-01 | 0.707 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.693383e-01 | 0.570 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.977399e-01 | 0.400 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.977399e-01 | 0.400 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 3.977399e-01 | 0.400 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.977399e-01 | 0.400 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 2.900511e-01 | 0.538 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.900511e-01 | 0.538 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.900511e-01 | 0.538 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 2.900511e-01 | 0.538 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.900511e-01 | 0.538 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.900511e-01 | 0.538 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 2.900511e-01 | 0.538 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.900511e-01 | 0.538 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.252275e-01 | 0.647 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.252275e-01 | 0.647 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 3.106893e-01 | 0.508 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.106893e-01 | 0.508 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.307434e-01 | 0.366 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 4.307434e-01 | 0.366 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 4.307434e-01 | 0.366 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.549202e-01 | 0.594 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.311989e-01 | 0.480 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 3.311989e-01 | 0.480 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 3.311989e-01 | 0.480 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.257191e-01 | 0.646 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.914907e-01 | 0.718 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.619403e-01 | 0.335 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.619403e-01 | 0.335 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.003190e-01 | 0.522 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.003190e-01 | 0.522 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.155668e-01 | 0.501 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.155668e-01 | 0.501 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 3.915062e-01 | 0.407 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.915062e-01 | 0.407 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.914292e-01 | 0.309 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.622945e-01 | 0.581 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.822379e-02 | 1.054 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 4.110775e-01 | 0.386 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.110775e-01 | 0.386 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.193037e-01 | 0.285 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.193037e-01 | 0.285 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 5.193037e-01 | 0.285 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.492480e-01 | 0.348 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.678027e-01 | 0.330 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.678027e-01 | 0.330 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.859796e-01 | 0.313 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.373099e-01 | 0.359 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.373099e-01 | 0.359 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.496367e-01 | 0.347 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.989353e-01 | 0.399 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.989353e-01 | 0.399 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.618763e-01 | 0.335 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 5.211451e-01 | 0.283 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.936065e-01 | 0.307 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.936065e-01 | 0.307 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.585279e-01 | 0.339 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.585279e-01 | 0.339 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.860577e-01 | 0.313 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.075129e-01 | 0.295 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.799495e-01 | 0.319 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.010772e-01 | 0.300 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.330094e-01 | 0.273 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.414375e-01 | 0.849 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.936065e-01 | 0.307 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.810657e-02 | 1.107 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.837548e-02 | 1.007 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.155668e-01 | 0.501 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.303328e-01 | 0.366 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.914907e-01 | 0.718 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.075599e-01 | 0.512 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.686762e-01 | 0.571 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.686762e-01 | 0.571 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.879366e-01 | 0.312 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.843913e-01 | 0.315 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.522732e-01 | 0.345 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.686762e-01 | 0.571 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.936065e-01 | 0.307 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 8.802937e-02 | 1.055 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.787168e-01 | 0.555 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.936065e-01 | 0.307 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.477094e-01 | 0.831 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.851105e-01 | 0.545 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.492480e-01 | 0.348 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.569131e-01 | 0.447 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.477094e-01 | 0.831 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.670420e-01 | 0.777 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.962835e-01 | 0.707 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.904100e-01 | 0.537 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.670420e-01 | 0.777 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.670420e-01 | 0.777 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.417305e-01 | 0.849 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.106455e-01 | 0.676 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.612957e-01 | 0.442 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.193037e-01 | 0.285 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 5.193037e-01 | 0.285 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.160116e-01 | 0.381 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.795077e-01 | 0.319 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.115163e-01 | 0.291 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.699681e-01 | 0.569 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.321186e-01 | 0.274 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.474304e-01 | 0.831 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 4.492480e-01 | 0.348 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.065359e-01 | 0.391 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 4.678027e-01 | 0.330 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.211451e-01 | 0.283 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.375488e-01 | 0.862 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.341455e-01 | 0.872 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.868136e-01 | 0.542 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.073945e-01 | 0.683 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.000144e-01 | 1.000 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.628252e-01 | 0.440 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 2.106455e-01 | 0.676 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.851105e-01 | 0.545 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.914292e-01 | 0.309 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.914292e-01 | 0.309 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.065359e-01 | 0.391 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.518000e-01 | 0.599 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.319267e-01 | 0.479 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.319267e-01 | 0.479 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.465996e-01 | 0.608 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.417305e-01 | 0.849 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 2.279382e-01 | 0.642 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.585279e-01 | 0.339 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.348570e-01 | 0.870 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.614550e-02 | 1.017 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.155668e-01 | 0.501 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.308281e-01 | 0.480 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.214160e-01 | 0.375 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.486114e-01 | 0.604 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.909804e-01 | 0.719 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.592634e-01 | 0.586 | 1 | 1 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.870646e-01 | 0.728 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.258887e-01 | 0.487 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.258887e-01 | 0.487 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.073945e-01 | 0.683 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.628252e-01 | 0.440 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.798019e-01 | 0.745 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 4.307434e-01 | 0.366 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.308281e-01 | 0.480 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 4.914292e-01 | 0.309 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.914292e-01 | 0.309 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.116151e-01 | 0.506 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.764575e-01 | 0.424 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.214160e-01 | 0.375 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.764018e-01 | 0.424 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.629594e-01 | 0.580 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.786885e-01 | 0.748 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.617408e-01 | 0.442 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.707244e-01 | 0.431 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.090148e-01 | 0.963 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.466188e-01 | 0.350 | 1 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.330094e-01 | 0.273 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.486114e-01 | 0.604 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.549202e-01 | 0.594 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.283023e-01 | 0.892 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.249054e-01 | 0.372 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.399964e-01 | 0.620 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.381132e-01 | 0.269 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.537995e-01 | 0.596 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.977399e-01 | 0.400 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.106455e-01 | 0.676 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.399964e-01 | 0.620 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.311989e-01 | 0.480 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.232502e-01 | 0.651 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.915438e-01 | 0.407 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.497091e-01 | 0.603 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.970160e-01 | 0.705 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.150093e-01 | 0.382 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.381132e-01 | 0.269 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.381132e-01 | 0.269 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.416196e-02 | 1.075 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.580200e-01 | 0.588 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.561585e-01 | 0.806 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.515322e-01 | 0.454 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.399964e-01 | 0.620 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.914292e-01 | 0.309 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.276270e-01 | 0.894 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.232502e-01 | 0.651 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.927720e-01 | 0.715 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.561585e-01 | 0.806 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.977837e-01 | 0.526 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 2.017453e-01 | 0.695 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.226899e-02 | 1.035 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.454761e-01 | 0.610 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 1.283446e-01 | 0.892 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.474304e-01 | 0.831 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 2.868136e-01 | 0.542 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.870646e-01 | 0.728 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.073945e-01 | 0.683 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.073945e-01 | 0.683 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.417305e-01 | 0.849 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 2.279382e-01 | 0.642 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 2.279382e-01 | 0.642 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 3.628252e-01 | 0.440 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.486114e-01 | 0.604 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.210356e-02 | 1.086 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 3.977399e-01 | 0.400 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.581495e-01 | 0.801 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.873247e-02 | 1.006 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 4.307434e-01 | 0.366 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.619403e-01 | 0.335 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.716470e-01 | 0.430 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.155668e-01 | 0.501 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.914292e-01 | 0.309 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.361864e-01 | 0.627 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.193037e-01 | 0.285 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.065359e-01 | 0.391 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.211451e-01 | 0.283 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.866029e-01 | 0.543 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.477094e-01 | 0.831 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.106893e-01 | 0.508 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.322408e-01 | 0.634 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.134826e-02 | 1.039 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.276333e-02 | 1.082 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.716470e-01 | 0.430 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.472883e-01 | 0.607 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.914907e-01 | 0.718 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.962835e-01 | 0.707 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.283023e-01 | 0.892 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.006441e-01 | 0.698 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.640131e-01 | 0.785 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 3.489372e-01 | 0.457 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.129620e-01 | 0.290 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.258887e-01 | 0.487 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.915062e-01 | 0.407 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.919472e-01 | 0.717 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.065359e-01 | 0.391 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.737825e-01 | 0.563 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.740194e-01 | 0.324 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.139563e-01 | 0.670 | 1 | 1 |
| Chromosome Maintenance | R-HSA-73886 | 2.349113e-01 | 0.629 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.900511e-01 | 0.538 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.678027e-01 | 0.330 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.160116e-01 | 0.381 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.459331e-01 | 0.836 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.561077e-01 | 0.807 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.329501e-02 | 1.030 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.460787e-01 | 0.461 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.765409e-01 | 0.753 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.276333e-02 | 1.082 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.354332e-02 | 1.029 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.279382e-01 | 0.642 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.628252e-01 | 0.440 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.656751e-02 | 1.063 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.307434e-01 | 0.366 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.619403e-01 | 0.335 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.914292e-01 | 0.309 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 5.193037e-01 | 0.285 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 5.193037e-01 | 0.285 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.652269e-01 | 0.332 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.800507e-01 | 0.553 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.934234e-01 | 0.307 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.515322e-01 | 0.454 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.515322e-01 | 0.454 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.329501e-02 | 1.030 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.329501e-02 | 1.030 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.329501e-02 | 1.030 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.329501e-02 | 1.030 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.099110e-01 | 0.959 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.800623e-02 | 1.108 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.316028e-01 | 0.274 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.889417e-01 | 0.410 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.934529e-01 | 0.713 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 8.119151e-02 | 1.090 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 5.075129e-01 | 0.295 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.294722e-01 | 0.482 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.115917e-01 | 0.952 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.725976e-01 | 0.564 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.905531e-01 | 0.309 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.779222e-01 | 0.750 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.709688e-01 | 0.431 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 1.283446e-01 | 0.892 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 2.868136e-01 | 0.542 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.628252e-01 | 0.440 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.693383e-01 | 0.570 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.977399e-01 | 0.400 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.977399e-01 | 0.400 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.062467e-01 | 0.974 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.252275e-01 | 0.647 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 4.307434e-01 | 0.366 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.311989e-01 | 0.480 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.311989e-01 | 0.480 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.851105e-01 | 0.545 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.851105e-01 | 0.545 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.619403e-01 | 0.335 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 4.914292e-01 | 0.309 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.303328e-01 | 0.366 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.193037e-01 | 0.285 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.193037e-01 | 0.285 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.193037e-01 | 0.285 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.037642e-01 | 0.298 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.618763e-01 | 0.335 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.381132e-01 | 0.269 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.330094e-01 | 0.273 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.131583e-01 | 0.290 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.889946e-02 | 1.103 | 1 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.246326e-01 | 0.280 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 4.065359e-01 | 0.391 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.519157e-01 | 0.818 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.209126e-01 | 0.283 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.458467e-01 | 0.836 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.914907e-01 | 0.718 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.303328e-01 | 0.366 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.303328e-01 | 0.366 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.474304e-01 | 0.831 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.000144e-01 | 1.000 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.000144e-01 | 1.000 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.550500e-01 | 0.810 | 1 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 3.003190e-01 | 0.522 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.303328e-01 | 0.366 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 4.859796e-01 | 0.313 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.453755e-01 | 0.462 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.798019e-01 | 0.745 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.072471e-01 | 0.513 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.211451e-01 | 0.283 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.015137e-01 | 0.993 | 1 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 9.226899e-02 | 1.035 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.474304e-01 | 0.831 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.279382e-01 | 0.642 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.693383e-01 | 0.570 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.798019e-01 | 0.745 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.043401e-01 | 0.982 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.241994e-01 | 0.489 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.303328e-01 | 0.366 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.193037e-01 | 0.285 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.214160e-01 | 0.375 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.124333e-01 | 0.385 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.446177e-01 | 0.840 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.984517e-01 | 0.400 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.984517e-01 | 0.400 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.072600e-01 | 0.295 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.678027e-01 | 0.330 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.477094e-01 | 0.831 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.063005e-01 | 0.973 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.651022e-01 | 0.438 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.519277e-01 | 0.599 | 1 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.099110e-01 | 0.959 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 2.868136e-01 | 0.542 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.258887e-01 | 0.487 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.279382e-01 | 0.642 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.962835e-01 | 0.707 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 3.977399e-01 | 0.400 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.900511e-01 | 0.538 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.798019e-01 | 0.745 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.307434e-01 | 0.366 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.023710e-01 | 0.694 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.914292e-01 | 0.309 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.492480e-01 | 0.348 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.873295e-01 | 0.412 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.381132e-01 | 0.269 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.688526e-01 | 0.772 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.851105e-01 | 0.545 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.269699e-01 | 0.485 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.910317e-01 | 0.536 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.279382e-01 | 0.642 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.800623e-02 | 1.108 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 4.492480e-01 | 0.348 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.549837e-01 | 0.593 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.837548e-02 | 1.007 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.670420e-01 | 0.777 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 3.379394e-01 | 0.471 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.081532e-01 | 0.294 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.800623e-02 | 1.108 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.492480e-01 | 0.348 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.003190e-01 | 0.522 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.709804e-01 | 0.431 | 1 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.709804e-01 | 0.431 | 1 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.936065e-01 | 0.307 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.991709e-01 | 0.524 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.283446e-01 | 0.892 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.354332e-02 | 1.029 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.289955e-01 | 0.889 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 3.628252e-01 | 0.440 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 8.782341e-02 | 1.056 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.693383e-01 | 0.570 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 3.977399e-01 | 0.400 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.900511e-01 | 0.538 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.914292e-01 | 0.309 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.914292e-01 | 0.309 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.381132e-01 | 0.269 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.212173e-01 | 0.283 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.381132e-01 | 0.269 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 5.142329e-01 | 0.289 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.909804e-01 | 0.719 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.900511e-01 | 0.538 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 3.515322e-01 | 0.454 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.381132e-01 | 0.269 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.477225e-01 | 0.349 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.910205e-01 | 0.536 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.743723e-01 | 0.324 | 1 | 1 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.671265e-01 | 0.777 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.693383e-01 | 0.570 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.106893e-01 | 0.508 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.311488e-01 | 0.636 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.110775e-01 | 0.386 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.381132e-01 | 0.269 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.330094e-01 | 0.273 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.740194e-01 | 0.324 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 1.181299e-01 | 0.928 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.241994e-01 | 0.489 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.561585e-01 | 0.806 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 9.279763e-02 | 1.032 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.640131e-01 | 0.785 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 5.037642e-01 | 0.298 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.390232e-01 | 0.358 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.493775e-01 | 0.347 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.628252e-01 | 0.440 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.106455e-01 | 0.676 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.347119e-01 | 0.475 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.072600e-01 | 0.295 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.497059e-01 | 0.456 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.266694e-01 | 0.897 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.037642e-01 | 0.298 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.037642e-01 | 0.298 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.075129e-01 | 0.295 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 3.258887e-01 | 0.487 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.962835e-01 | 0.707 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.307434e-01 | 0.366 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.376424e-01 | 0.624 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.692724e-01 | 0.329 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.229562e-01 | 0.652 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.141777e-01 | 0.383 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.670420e-01 | 0.777 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.678027e-01 | 0.330 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.330175e-01 | 0.273 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.361677e-01 | 0.360 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.577340e-01 | 0.339 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.709804e-01 | 0.431 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.056308e-01 | 0.687 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 4.061227e-01 | 0.391 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.795077e-01 | 0.319 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.675606e-01 | 0.573 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 5.037642e-01 | 0.298 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.072471e-01 | 0.513 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.549202e-01 | 0.594 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.252275e-01 | 0.647 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 3.716470e-01 | 0.430 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.303328e-01 | 0.366 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.361677e-01 | 0.360 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 2.023710e-01 | 0.694 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.347110e-01 | 0.272 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.936065e-01 | 0.307 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 2.851105e-01 | 0.545 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 9.733064e-02 | 1.012 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.795077e-01 | 0.319 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.444132e-01 | 0.264 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.456519e-01 | 0.263 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.456519e-01 | 0.263 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.456519e-01 | 0.263 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.456519e-01 | 0.263 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 5.456519e-01 | 0.263 | 0 | 0 |
| Hormone ligand-binding receptors | R-HSA-375281 | 5.456519e-01 | 0.263 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 5.456519e-01 | 0.263 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 5.456519e-01 | 0.263 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.456519e-01 | 0.263 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.456519e-01 | 0.263 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.479864e-01 | 0.261 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.479864e-01 | 0.261 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.517532e-01 | 0.258 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.523212e-01 | 0.258 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.523212e-01 | 0.258 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.540151e-01 | 0.256 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.546613e-01 | 0.256 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.546613e-01 | 0.256 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.546613e-01 | 0.256 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.546613e-01 | 0.256 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.546613e-01 | 0.256 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 5.546613e-01 | 0.256 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.556715e-01 | 0.255 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.556715e-01 | 0.255 | 1 | 1 |
| HCMV Infection | R-HSA-9609646 | 5.565006e-01 | 0.255 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.610367e-01 | 0.251 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.681497e-01 | 0.246 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.705575e-01 | 0.244 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.705575e-01 | 0.244 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.705575e-01 | 0.244 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.705575e-01 | 0.244 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.705575e-01 | 0.244 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 5.705575e-01 | 0.244 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.705575e-01 | 0.244 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 5.705575e-01 | 0.244 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.705575e-01 | 0.244 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.705575e-01 | 0.244 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 5.705575e-01 | 0.244 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 5.705575e-01 | 0.244 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 5.705575e-01 | 0.244 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.707846e-01 | 0.244 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.707846e-01 | 0.244 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.707846e-01 | 0.244 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.707846e-01 | 0.244 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.707846e-01 | 0.244 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.708332e-01 | 0.243 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.719586e-01 | 0.243 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.738561e-01 | 0.241 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.738561e-01 | 0.241 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.738561e-01 | 0.241 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.817249e-01 | 0.235 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.861928e-01 | 0.232 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 5.864395e-01 | 0.232 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.864395e-01 | 0.232 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.864800e-01 | 0.232 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 5.864800e-01 | 0.232 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.864800e-01 | 0.232 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.864800e-01 | 0.232 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.911684e-01 | 0.228 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.940992e-01 | 0.226 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.940992e-01 | 0.226 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.940992e-01 | 0.226 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.940992e-01 | 0.226 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 5.940992e-01 | 0.226 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.940992e-01 | 0.226 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.940992e-01 | 0.226 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.940992e-01 | 0.226 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.940992e-01 | 0.226 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.940992e-01 | 0.226 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.940992e-01 | 0.226 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.940992e-01 | 0.226 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.987825e-01 | 0.223 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.991551e-01 | 0.222 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 6.006053e-01 | 0.221 | 1 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.008638e-01 | 0.221 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.017459e-01 | 0.221 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.017459e-01 | 0.221 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.108815e-01 | 0.214 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.108815e-01 | 0.214 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.117104e-01 | 0.213 | 1 | 1 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.163518e-01 | 0.210 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.163518e-01 | 0.210 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.163518e-01 | 0.210 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 6.163518e-01 | 0.210 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 6.163518e-01 | 0.210 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 6.163518e-01 | 0.210 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 6.163518e-01 | 0.210 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.163518e-01 | 0.210 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.163518e-01 | 0.210 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.163518e-01 | 0.210 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 6.165822e-01 | 0.210 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 6.165822e-01 | 0.210 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 6.165822e-01 | 0.210 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.184048e-01 | 0.209 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.199125e-01 | 0.208 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 6.309901e-01 | 0.200 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.309901e-01 | 0.200 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.368001e-01 | 0.196 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.373857e-01 | 0.196 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.373857e-01 | 0.196 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.373857e-01 | 0.196 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 6.373857e-01 | 0.196 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.373857e-01 | 0.196 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.373857e-01 | 0.196 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 6.373857e-01 | 0.196 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.373857e-01 | 0.196 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.374648e-01 | 0.196 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.374648e-01 | 0.196 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.399816e-01 | 0.194 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.449721e-01 | 0.190 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.449721e-01 | 0.190 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.449721e-01 | 0.190 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 6.449721e-01 | 0.190 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.449721e-01 | 0.190 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.449721e-01 | 0.190 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.456887e-01 | 0.190 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.497526e-01 | 0.187 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.506657e-01 | 0.187 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.516026e-01 | 0.186 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.549678e-01 | 0.184 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.567888e-01 | 0.183 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.567888e-01 | 0.183 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.567888e-01 | 0.183 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.572675e-01 | 0.182 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.572675e-01 | 0.182 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.572675e-01 | 0.182 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.572675e-01 | 0.182 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.572675e-01 | 0.182 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 6.572675e-01 | 0.182 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.572675e-01 | 0.182 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.572675e-01 | 0.182 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.572675e-01 | 0.182 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.572675e-01 | 0.182 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.572675e-01 | 0.182 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 6.576218e-01 | 0.182 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.676365e-01 | 0.175 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.676365e-01 | 0.175 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.676365e-01 | 0.175 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 6.676365e-01 | 0.175 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.676365e-01 | 0.175 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.716724e-01 | 0.173 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.716724e-01 | 0.173 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.716724e-01 | 0.173 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.716724e-01 | 0.173 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.719211e-01 | 0.173 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.760604e-01 | 0.170 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.760604e-01 | 0.170 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.760604e-01 | 0.170 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.760604e-01 | 0.170 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.760604e-01 | 0.170 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.760604e-01 | 0.170 | 0 | 0 |
| Mineralocorticoid biosynthesis | R-HSA-193993 | 6.760604e-01 | 0.170 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.779933e-01 | 0.169 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.782315e-01 | 0.169 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 6.844002e-01 | 0.165 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.870462e-01 | 0.163 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.870462e-01 | 0.163 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.885743e-01 | 0.162 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.885743e-01 | 0.162 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 6.938239e-01 | 0.159 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.938239e-01 | 0.159 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.959179e-01 | 0.157 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.967205e-01 | 0.157 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.967205e-01 | 0.157 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.986656e-01 | 0.156 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.986656e-01 | 0.156 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.986656e-01 | 0.156 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.986656e-01 | 0.156 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.990693e-01 | 0.155 | 1 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.038035e-01 | 0.153 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.049824e-01 | 0.152 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.054525e-01 | 0.152 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.086399e-01 | 0.150 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 7.086399e-01 | 0.150 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 7.086399e-01 | 0.150 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.106144e-01 | 0.148 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.106144e-01 | 0.148 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.106144e-01 | 0.148 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.106144e-01 | 0.148 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 7.106144e-01 | 0.148 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.106144e-01 | 0.148 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 7.106144e-01 | 0.148 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.106144e-01 | 0.148 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.125234e-01 | 0.147 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 7.131173e-01 | 0.147 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.180991e-01 | 0.144 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.180991e-01 | 0.144 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.201651e-01 | 0.143 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.263134e-01 | 0.139 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.264850e-01 | 0.139 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.264850e-01 | 0.139 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.264850e-01 | 0.139 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.264850e-01 | 0.139 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.264850e-01 | 0.139 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.264850e-01 | 0.139 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.264850e-01 | 0.139 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.264850e-01 | 0.139 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 7.264850e-01 | 0.139 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.264850e-01 | 0.139 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 7.264850e-01 | 0.139 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 7.264850e-01 | 0.139 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.264850e-01 | 0.139 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.268235e-01 | 0.139 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.271360e-01 | 0.138 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.274448e-01 | 0.138 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.313036e-01 | 0.136 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.340984e-01 | 0.134 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.340984e-01 | 0.134 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.340984e-01 | 0.134 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.340984e-01 | 0.134 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.346646e-01 | 0.134 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.365255e-01 | 0.133 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.365458e-01 | 0.133 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.387851e-01 | 0.131 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.412315e-01 | 0.130 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 7.414862e-01 | 0.130 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.414862e-01 | 0.130 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.414862e-01 | 0.130 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.414862e-01 | 0.130 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 7.414862e-01 | 0.130 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.414862e-01 | 0.130 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.414862e-01 | 0.130 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 7.414862e-01 | 0.130 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.414862e-01 | 0.130 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 7.414862e-01 | 0.130 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.414862e-01 | 0.130 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.414862e-01 | 0.130 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.420630e-01 | 0.130 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.420630e-01 | 0.130 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.420630e-01 | 0.130 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.420630e-01 | 0.130 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.420630e-01 | 0.130 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.422450e-01 | 0.129 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.453509e-01 | 0.128 | 1 | 1 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.454047e-01 | 0.128 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 7.454047e-01 | 0.128 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.524515e-01 | 0.124 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.524515e-01 | 0.124 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.556655e-01 | 0.122 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.556655e-01 | 0.122 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.556655e-01 | 0.122 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.556655e-01 | 0.122 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.556655e-01 | 0.122 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.556655e-01 | 0.122 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.556655e-01 | 0.122 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.556655e-01 | 0.122 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.559405e-01 | 0.122 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 7.572877e-01 | 0.121 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 7.606876e-01 | 0.119 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.624074e-01 | 0.118 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.624074e-01 | 0.118 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.624074e-01 | 0.118 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.624774e-01 | 0.118 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 7.624774e-01 | 0.118 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.624774e-01 | 0.118 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.624774e-01 | 0.118 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 7.624774e-01 | 0.118 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.631959e-01 | 0.117 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.680739e-01 | 0.115 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 7.690678e-01 | 0.114 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.690678e-01 | 0.114 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.690678e-01 | 0.114 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.690678e-01 | 0.114 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.690678e-01 | 0.114 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 7.690678e-01 | 0.114 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.690678e-01 | 0.114 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.700166e-01 | 0.113 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 7.721491e-01 | 0.112 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 7.721491e-01 | 0.112 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.721491e-01 | 0.112 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.721491e-01 | 0.112 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.747870e-01 | 0.111 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.747870e-01 | 0.111 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.747870e-01 | 0.111 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.784773e-01 | 0.109 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.817358e-01 | 0.107 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.817358e-01 | 0.107 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.817358e-01 | 0.107 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 7.817358e-01 | 0.107 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.874910e-01 | 0.104 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.904649e-01 | 0.102 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 7.936420e-01 | 0.100 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.936420e-01 | 0.100 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.937096e-01 | 0.100 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.937096e-01 | 0.100 | 0 | 0 |
| Reactions specific to the complex N-glycan synthesis pathway | R-HSA-975578 | 7.937096e-01 | 0.100 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.937096e-01 | 0.100 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.937096e-01 | 0.100 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.937096e-01 | 0.100 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.937096e-01 | 0.100 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.949889e-01 | 0.100 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.949889e-01 | 0.100 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.991266e-01 | 0.097 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.991266e-01 | 0.097 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 7.991266e-01 | 0.097 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 8.008942e-01 | 0.096 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.049058e-01 | 0.094 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.049058e-01 | 0.094 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.049058e-01 | 0.094 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.050271e-01 | 0.094 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 8.050271e-01 | 0.094 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.050271e-01 | 0.094 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.050271e-01 | 0.094 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.050271e-01 | 0.094 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.074694e-01 | 0.093 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.074694e-01 | 0.093 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.074694e-01 | 0.093 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.074694e-01 | 0.093 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.074694e-01 | 0.093 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.074694e-01 | 0.093 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.105299e-01 | 0.091 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.137412e-01 | 0.090 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.147577e-01 | 0.089 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.147577e-01 | 0.089 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.155022e-01 | 0.089 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.155022e-01 | 0.089 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.155022e-01 | 0.089 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.157245e-01 | 0.088 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.157245e-01 | 0.088 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.157245e-01 | 0.088 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.157245e-01 | 0.088 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.157245e-01 | 0.088 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.157245e-01 | 0.088 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.157245e-01 | 0.088 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.168235e-01 | 0.088 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 8.213771e-01 | 0.085 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.213771e-01 | 0.085 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 8.213771e-01 | 0.085 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.230845e-01 | 0.085 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.232338e-01 | 0.084 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.232338e-01 | 0.084 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.235044e-01 | 0.084 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.246618e-01 | 0.084 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.254450e-01 | 0.083 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.254450e-01 | 0.083 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.258355e-01 | 0.083 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.258355e-01 | 0.083 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.258355e-01 | 0.083 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.258355e-01 | 0.083 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.258355e-01 | 0.083 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.258355e-01 | 0.083 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 8.258355e-01 | 0.083 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.258355e-01 | 0.083 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 8.258355e-01 | 0.083 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.258355e-01 | 0.083 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.271730e-01 | 0.082 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.277938e-01 | 0.082 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.286055e-01 | 0.082 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.306731e-01 | 0.081 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.306731e-01 | 0.081 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.339719e-01 | 0.079 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.340121e-01 | 0.079 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.351314e-01 | 0.078 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.353923e-01 | 0.078 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 8.353923e-01 | 0.078 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.353923e-01 | 0.078 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.353923e-01 | 0.078 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.353923e-01 | 0.078 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.378290e-01 | 0.077 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.418527e-01 | 0.075 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.444253e-01 | 0.073 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.444253e-01 | 0.073 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.444253e-01 | 0.073 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.444253e-01 | 0.073 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.444253e-01 | 0.073 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 8.444253e-01 | 0.073 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.444253e-01 | 0.073 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.447100e-01 | 0.073 | 1 | 1 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.458703e-01 | 0.073 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.470260e-01 | 0.072 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.470260e-01 | 0.072 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.509790e-01 | 0.070 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.513248e-01 | 0.070 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.513248e-01 | 0.070 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.520557e-01 | 0.070 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.529631e-01 | 0.069 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.529631e-01 | 0.069 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.554926e-01 | 0.068 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.554926e-01 | 0.068 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.576818e-01 | 0.067 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.576818e-01 | 0.067 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.610328e-01 | 0.065 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.610328e-01 | 0.065 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 8.610328e-01 | 0.065 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.610328e-01 | 0.065 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.610328e-01 | 0.065 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.610328e-01 | 0.065 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.622764e-01 | 0.064 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 8.622764e-01 | 0.064 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.637895e-01 | 0.064 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.656890e-01 | 0.063 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.673940e-01 | 0.062 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.683541e-01 | 0.061 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.683541e-01 | 0.061 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.686601e-01 | 0.061 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.686601e-01 | 0.061 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.751452e-01 | 0.058 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 8.752894e-01 | 0.058 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.758692e-01 | 0.058 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.758692e-01 | 0.058 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 8.758692e-01 | 0.058 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.771284e-01 | 0.057 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.802363e-01 | 0.055 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.802363e-01 | 0.055 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.806976e-01 | 0.055 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.826830e-01 | 0.054 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.826830e-01 | 0.054 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.834708e-01 | 0.054 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.858884e-01 | 0.053 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.862233e-01 | 0.052 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.864858e-01 | 0.052 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.891232e-01 | 0.051 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 8.891232e-01 | 0.051 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.905415e-01 | 0.050 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.908692e-01 | 0.050 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.908692e-01 | 0.050 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.908692e-01 | 0.050 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.946465e-01 | 0.048 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.947123e-01 | 0.048 | 1 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.950523e-01 | 0.048 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.952102e-01 | 0.048 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.952102e-01 | 0.048 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.952102e-01 | 0.048 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.952102e-01 | 0.048 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.952102e-01 | 0.048 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.952102e-01 | 0.048 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.956475e-01 | 0.048 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.987398e-01 | 0.046 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.002305e-01 | 0.046 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.002305e-01 | 0.046 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.009634e-01 | 0.045 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.009634e-01 | 0.045 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.009634e-01 | 0.045 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.009634e-01 | 0.045 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.021827e-01 | 0.045 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.022003e-01 | 0.045 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.046252e-01 | 0.044 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.046252e-01 | 0.044 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.063810e-01 | 0.043 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.064011e-01 | 0.043 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.064011e-01 | 0.043 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.064011e-01 | 0.043 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.068000e-01 | 0.042 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.088385e-01 | 0.042 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.115405e-01 | 0.040 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.115405e-01 | 0.040 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.115405e-01 | 0.040 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.115405e-01 | 0.040 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.115405e-01 | 0.040 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.121161e-01 | 0.040 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.121161e-01 | 0.040 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.128770e-01 | 0.040 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.128770e-01 | 0.040 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.153989e-01 | 0.038 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.163980e-01 | 0.038 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.163980e-01 | 0.038 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.163980e-01 | 0.038 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.163980e-01 | 0.038 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.163980e-01 | 0.038 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.163980e-01 | 0.038 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 9.163980e-01 | 0.038 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.163980e-01 | 0.038 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 9.167473e-01 | 0.038 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.167473e-01 | 0.038 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.168667e-01 | 0.038 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.168667e-01 | 0.038 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.190221e-01 | 0.037 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 9.195996e-01 | 0.036 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.201168e-01 | 0.036 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.209891e-01 | 0.036 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.209891e-01 | 0.036 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.209891e-01 | 0.036 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.209891e-01 | 0.036 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.209891e-01 | 0.036 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.209891e-01 | 0.036 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.211267e-01 | 0.036 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.240079e-01 | 0.034 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.252707e-01 | 0.034 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.253283e-01 | 0.034 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.262711e-01 | 0.033 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.274103e-01 | 0.033 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.274103e-01 | 0.033 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.294294e-01 | 0.032 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.294294e-01 | 0.032 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.294294e-01 | 0.032 | 0 | 0 |
| N-glycan antennae elongation in the medial/trans-Golgi | R-HSA-975576 | 9.294294e-01 | 0.032 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.306685e-01 | 0.031 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.333055e-01 | 0.030 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.337881e-01 | 0.030 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.337881e-01 | 0.030 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.361199e-01 | 0.029 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.361199e-01 | 0.029 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 9.367012e-01 | 0.028 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.367744e-01 | 0.028 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.367744e-01 | 0.028 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.369690e-01 | 0.028 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.369690e-01 | 0.028 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.369690e-01 | 0.028 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 9.369690e-01 | 0.028 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.369690e-01 | 0.028 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.369690e-01 | 0.028 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.369690e-01 | 0.028 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.372940e-01 | 0.028 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.398012e-01 | 0.027 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.398012e-01 | 0.027 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.402573e-01 | 0.027 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.404314e-01 | 0.027 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.404314e-01 | 0.027 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.404314e-01 | 0.027 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.437038e-01 | 0.025 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.437038e-01 | 0.025 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.437038e-01 | 0.025 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.448750e-01 | 0.025 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.449625e-01 | 0.025 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.449852e-01 | 0.025 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.467765e-01 | 0.024 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.467967e-01 | 0.024 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.467967e-01 | 0.024 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 9.467967e-01 | 0.024 | 1 | 1 |
| Methylation | R-HSA-156581 | 9.467967e-01 | 0.024 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.467967e-01 | 0.024 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.474890e-01 | 0.023 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.474890e-01 | 0.023 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.489294e-01 | 0.023 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.497198e-01 | 0.022 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.497198e-01 | 0.022 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.497198e-01 | 0.022 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.497198e-01 | 0.022 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.497198e-01 | 0.022 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.498840e-01 | 0.022 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.524825e-01 | 0.021 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.543648e-01 | 0.020 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.543648e-01 | 0.020 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.550935e-01 | 0.020 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.550935e-01 | 0.020 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.564591e-01 | 0.019 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.575612e-01 | 0.019 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.575612e-01 | 0.019 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.585279e-01 | 0.018 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.588472e-01 | 0.018 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.598934e-01 | 0.018 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.598934e-01 | 0.018 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.598934e-01 | 0.018 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.620976e-01 | 0.017 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.636574e-01 | 0.016 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.641808e-01 | 0.016 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.644121e-01 | 0.016 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.652838e-01 | 0.015 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.656214e-01 | 0.015 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.660558e-01 | 0.015 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.661497e-01 | 0.015 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.678120e-01 | 0.014 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.701966e-01 | 0.013 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.701966e-01 | 0.013 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.714309e-01 | 0.013 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.714309e-01 | 0.013 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.715869e-01 | 0.013 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.722963e-01 | 0.012 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.727649e-01 | 0.012 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.730016e-01 | 0.012 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.744860e-01 | 0.011 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.772147e-01 | 0.010 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.776503e-01 | 0.010 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.781388e-01 | 0.010 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.784678e-01 | 0.009 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.784678e-01 | 0.009 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.787027e-01 | 0.009 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.796519e-01 | 0.009 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.806655e-01 | 0.008 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.806655e-01 | 0.008 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.807710e-01 | 0.008 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 9.818287e-01 | 0.008 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.844821e-01 | 0.007 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.845775e-01 | 0.007 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.846655e-01 | 0.007 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.848357e-01 | 0.007 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.851033e-01 | 0.007 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.855091e-01 | 0.006 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.855091e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.855091e-01 | 0.006 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.857191e-01 | 0.006 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.865092e-01 | 0.006 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.866623e-01 | 0.006 | 1 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.870184e-01 | 0.006 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.877719e-01 | 0.005 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.879713e-01 | 0.005 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.884448e-01 | 0.005 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.884448e-01 | 0.005 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.886950e-01 | 0.005 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.887086e-01 | 0.005 | 1 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.892020e-01 | 0.005 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.892020e-01 | 0.005 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.896816e-01 | 0.005 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.897251e-01 | 0.004 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.901145e-01 | 0.004 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.901274e-01 | 0.004 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.902471e-01 | 0.004 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.902471e-01 | 0.004 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.907739e-01 | 0.004 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.907862e-01 | 0.004 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.916641e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.917727e-01 | 0.004 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.922256e-01 | 0.003 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.922256e-01 | 0.003 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.927523e-01 | 0.003 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.930581e-01 | 0.003 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.934262e-01 | 0.003 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.934404e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.943492e-01 | 0.002 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.943492e-01 | 0.002 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.947721e-01 | 0.002 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.950583e-01 | 0.002 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.955878e-01 | 0.002 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.960462e-01 | 0.002 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.962776e-01 | 0.002 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.964840e-01 | 0.002 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.968596e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.970327e-01 | 0.001 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.973508e-01 | 0.001 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.974051e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.976348e-01 | 0.001 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.976348e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.981148e-01 | 0.001 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.982187e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.983999e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.985132e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.985284e-01 | 0.001 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.985552e-01 | 0.001 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.986271e-01 | 0.001 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.986271e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.986271e-01 | 0.001 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.989336e-01 | 0.000 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.989900e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.990457e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.991736e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.991994e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.992190e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.992396e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.992955e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.993212e-01 | 0.000 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.994832e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.995172e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.995691e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.995857e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.996567e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.996759e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.996803e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.996999e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.997749e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.997749e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999123e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999151e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999152e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999247e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999300e-01 | 0.000 | 1 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.999340e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999436e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999443e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999452e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999483e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999513e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.999622e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.999622e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999785e-01 | 0.000 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.999789e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999801e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999803e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999826e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999940e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999952e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.999956e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999959e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999966e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999977e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.999982e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999988e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999992e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999992e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999992e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999998e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.000000e+00 | 0.000 | 1 | 1 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.000000e+00 | 0.000 | 1 | 1 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.000000e+00 | 0.000 | 1 | 1 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.000000e+00 | 0.000 | 1 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.000000e+00 | 0.000 | 1 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 1.000000e+00 | 0.000 | 1 | 1 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.000000e+00 | 0.000 | 1 | 1 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.000000e+00 | 0.000 | 1 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 1.000000e+00 | 0.000 | 1 | 1 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.000000e+00 | 0.000 | 1 | 1 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.000000e+00 | 0.000 | 1 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.909584e-14 | 13.719 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.565414e-14 | 13.805 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.285871e-11 | 10.891 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.269961e-10 | 9.644 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.577048e-08 | 7.067 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.993690e-08 | 7.097 | 1 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.125573e-08 | 7.147 | 1 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.692571e-07 | 6.245 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.996471e-07 | 6.155 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 7.880177e-07 | 6.103 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.176189e-07 | 6.037 | 1 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.046969e-06 | 5.980 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.392970e-06 | 5.856 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.336286e-06 | 5.874 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.554885e-06 | 5.808 | 1 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.169658e-06 | 5.287 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 7.009416e-06 | 5.154 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 7.009416e-06 | 5.154 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.593664e-06 | 5.181 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.250464e-05 | 4.903 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.646968e-05 | 4.783 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.150374e-05 | 4.667 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.928750e-05 | 4.533 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.577150e-05 | 4.446 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.367538e-05 | 4.360 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.561007e-05 | 4.341 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.857919e-05 | 4.232 | 1 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.773775e-05 | 4.239 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.258935e-05 | 4.139 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 8.201659e-05 | 4.086 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.066281e-05 | 4.043 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.066281e-05 | 4.043 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.105271e-04 | 3.957 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.125252e-04 | 3.949 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.178180e-04 | 3.929 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.871483e-04 | 3.728 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.099562e-04 | 3.678 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.624211e-04 | 3.581 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.041391e-04 | 3.517 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.537312e-04 | 3.451 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.119706e-04 | 3.385 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.046236e-04 | 3.393 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.176278e-04 | 3.379 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.808409e-04 | 3.318 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.837502e-04 | 3.315 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.925269e-04 | 3.308 | 1 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.965500e-04 | 3.304 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.627601e-04 | 3.250 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.627601e-04 | 3.250 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.608794e-04 | 3.119 | 1 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 7.855471e-04 | 3.105 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 7.855471e-04 | 3.105 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.360416e-04 | 3.078 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.516353e-04 | 3.070 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.627518e-04 | 3.016 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.009464e-03 | 2.996 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.009464e-03 | 2.996 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.103191e-03 | 2.957 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.094599e-03 | 2.961 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.086385e-03 | 2.964 | 1 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.158541e-03 | 2.936 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.261843e-03 | 2.899 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.256393e-03 | 2.901 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.267123e-03 | 2.897 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.462258e-03 | 2.835 | 1 | 1 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.514959e-03 | 2.820 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.560367e-03 | 2.807 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.571253e-03 | 2.804 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.801208e-03 | 2.744 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.801208e-03 | 2.744 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.849446e-03 | 2.733 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.849446e-03 | 2.733 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.158324e-03 | 2.666 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.695574e-03 | 2.569 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.792104e-03 | 2.554 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.038752e-03 | 2.517 | 1 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.502227e-03 | 2.456 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.516624e-03 | 2.454 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.606710e-03 | 2.443 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.714891e-03 | 2.430 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.841086e-03 | 2.416 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.100019e-03 | 2.387 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.100019e-03 | 2.387 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.330278e-03 | 2.363 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.876061e-03 | 2.312 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.376535e-03 | 2.269 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.376535e-03 | 2.269 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 5.382878e-03 | 2.269 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.602125e-03 | 2.252 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.846780e-03 | 2.233 | 1 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.113525e-03 | 2.214 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.325874e-03 | 2.199 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.443689e-03 | 2.191 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.732557e-03 | 2.172 | 1 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.827980e-03 | 2.166 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.827980e-03 | 2.166 | 1 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.714290e-03 | 2.113 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.871010e-03 | 2.104 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.581052e-03 | 2.120 | 1 | 1 |
| Mitotic Prometaphase | R-HSA-68877 | 7.558129e-03 | 2.122 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 8.360243e-03 | 2.078 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 8.366358e-03 | 2.077 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.461833e-03 | 2.073 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 8.575632e-03 | 2.067 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.750508e-03 | 2.058 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.765657e-03 | 2.057 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.854629e-03 | 2.053 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.574272e-03 | 2.019 | 1 | 1 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.701202e-03 | 2.013 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.607363e-03 | 2.017 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.165016e-02 | 1.934 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.185008e-02 | 1.926 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.191359e-02 | 1.924 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.227609e-02 | 1.911 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.284858e-02 | 1.891 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.305479e-02 | 1.884 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.312205e-02 | 1.882 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.347304e-02 | 1.871 | 1 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.418188e-02 | 1.848 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.473680e-02 | 1.832 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.473680e-02 | 1.832 | 1 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.496448e-02 | 1.825 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.599955e-02 | 1.796 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 1.599955e-02 | 1.796 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.631196e-02 | 1.787 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.632934e-02 | 1.787 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.632934e-02 | 1.787 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.740292e-02 | 1.759 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.778077e-02 | 1.750 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.823717e-02 | 1.739 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.100257e-02 | 1.678 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.160994e-02 | 1.665 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.167254e-02 | 1.664 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.167254e-02 | 1.664 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.167254e-02 | 1.664 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.167254e-02 | 1.664 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.167254e-02 | 1.664 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.172767e-02 | 1.663 | 1 | 0 |
| Myogenesis | R-HSA-525793 | 2.340399e-02 | 1.631 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.385363e-02 | 1.622 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.385363e-02 | 1.622 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.385363e-02 | 1.622 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.444181e-02 | 1.612 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.643150e-02 | 1.578 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.751869e-02 | 1.560 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.784818e-02 | 1.555 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.784818e-02 | 1.555 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.892076e-02 | 1.539 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.929420e-02 | 1.533 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.957392e-02 | 1.529 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.970883e-02 | 1.527 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.970883e-02 | 1.527 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.983980e-02 | 1.525 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.991244e-02 | 1.524 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.188713e-02 | 1.496 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.188713e-02 | 1.496 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.214523e-02 | 1.493 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.344028e-02 | 1.476 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.344028e-02 | 1.476 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.659539e-02 | 1.437 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.671023e-02 | 1.435 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.673781e-02 | 1.435 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.685495e-02 | 1.434 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.742173e-02 | 1.427 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.324032e-02 | 1.364 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.799772e-02 | 1.420 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.799772e-02 | 1.420 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.799772e-02 | 1.420 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.799772e-02 | 1.420 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.975399e-02 | 1.401 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.100738e-02 | 1.387 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.081058e-02 | 1.389 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.081058e-02 | 1.389 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.081058e-02 | 1.389 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.324032e-02 | 1.364 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.911250e-02 | 1.408 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.188617e-02 | 1.378 | 1 | 1 |
| Deubiquitination | R-HSA-5688426 | 4.270801e-02 | 1.369 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.305963e-02 | 1.366 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.402328e-02 | 1.356 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.477703e-02 | 1.349 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.646100e-02 | 1.333 | 1 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 4.797821e-02 | 1.319 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.797821e-02 | 1.319 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.920266e-02 | 1.308 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.017019e-02 | 1.300 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.049532e-02 | 1.297 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 5.223339e-02 | 1.282 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.223339e-02 | 1.282 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.240978e-02 | 1.281 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.240978e-02 | 1.281 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.240978e-02 | 1.281 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.766158e-02 | 1.239 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.766158e-02 | 1.239 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.766158e-02 | 1.239 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.036980e-02 | 1.219 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.579355e-02 | 1.253 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.616168e-02 | 1.251 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.118685e-02 | 1.213 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.050483e-02 | 1.218 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.766158e-02 | 1.239 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.050483e-02 | 1.218 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.050483e-02 | 1.218 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.661954e-02 | 1.247 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.661954e-02 | 1.247 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.140697e-02 | 1.212 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.143269e-02 | 1.212 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.143269e-02 | 1.212 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.144778e-02 | 1.211 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 6.144778e-02 | 1.211 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.255242e-02 | 1.204 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 6.255242e-02 | 1.204 | 1 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 6.255242e-02 | 1.204 | 1 | 1 |
| Gastrulation | R-HSA-9758941 | 6.272379e-02 | 1.203 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.296210e-02 | 1.201 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.302871e-02 | 1.200 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.302871e-02 | 1.200 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.444270e-02 | 1.191 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.741605e-02 | 1.171 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.741605e-02 | 1.171 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.741605e-02 | 1.171 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.741605e-02 | 1.171 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.780027e-02 | 1.169 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 7.089177e-02 | 1.149 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.214646e-02 | 1.142 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.214646e-02 | 1.142 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.214646e-02 | 1.142 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.866951e-02 | 1.104 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.042271e-02 | 1.095 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.701187e-02 | 1.113 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.197862e-02 | 1.143 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.918418e-02 | 1.160 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.456396e-02 | 1.127 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.068840e-02 | 1.093 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.374576e-02 | 1.132 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 7.089177e-02 | 1.149 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.689346e-02 | 1.114 | 1 | 1 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.038626e-02 | 1.095 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.038626e-02 | 1.095 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.866951e-02 | 1.104 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.264501e-02 | 1.083 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.182163e-02 | 1.087 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.214646e-02 | 1.142 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.619870e-02 | 1.118 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 7.311375e-02 | 1.136 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.315680e-02 | 1.080 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 8.315680e-02 | 1.080 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 8.444158e-02 | 1.073 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.448220e-02 | 1.073 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.566885e-02 | 1.067 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.566885e-02 | 1.067 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.643043e-02 | 1.063 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.643043e-02 | 1.063 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.711704e-02 | 1.060 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.772708e-02 | 1.057 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 8.807885e-02 | 1.055 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 8.807885e-02 | 1.055 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.807885e-02 | 1.055 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.872677e-02 | 1.052 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.115139e-02 | 1.040 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.264923e-02 | 1.033 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.481602e-02 | 1.023 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 9.657847e-02 | 1.015 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 9.657847e-02 | 1.015 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 9.657847e-02 | 1.015 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 9.657847e-02 | 1.015 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 9.685376e-02 | 1.014 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 9.857698e-02 | 1.006 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 9.857698e-02 | 1.006 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.008926e-01 | 0.996 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.009014e-01 | 0.996 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 1.244194e-01 | 0.905 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 1.244194e-01 | 0.905 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.244194e-01 | 0.905 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.244194e-01 | 0.905 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.053395e-01 | 0.977 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.268765e-01 | 0.897 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 1.257232e-01 | 0.901 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.257232e-01 | 0.901 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.200151e-01 | 0.921 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.167627e-01 | 0.933 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.189098e-01 | 0.925 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.026504e-01 | 0.989 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.244194e-01 | 0.905 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.149569e-01 | 0.939 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.200151e-01 | 0.921 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.244194e-01 | 0.905 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.053010e-01 | 0.978 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.123293e-01 | 0.950 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.230268e-01 | 0.910 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.065669e-01 | 0.972 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.189647e-01 | 0.925 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.129516e-01 | 0.947 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.200315e-01 | 0.921 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.100529e-01 | 0.958 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.177086e-01 | 0.929 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.268765e-01 | 0.897 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.236383e-01 | 0.908 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.244194e-01 | 0.905 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.129516e-01 | 0.947 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.270467e-01 | 0.896 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.274271e-01 | 0.895 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.274271e-01 | 0.895 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.274271e-01 | 0.895 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.274271e-01 | 0.895 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.285116e-01 | 0.891 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.306791e-01 | 0.884 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.332012e-01 | 0.875 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.343000e-01 | 0.872 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.343000e-01 | 0.872 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.385440e-01 | 0.858 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.414397e-01 | 0.849 | 1 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.418376e-01 | 0.848 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.421651e-01 | 0.847 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.421651e-01 | 0.847 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.424691e-01 | 0.846 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.425162e-01 | 0.846 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.594031e-01 | 0.798 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.594031e-01 | 0.798 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.594031e-01 | 0.798 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.594031e-01 | 0.798 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.594031e-01 | 0.798 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.594031e-01 | 0.798 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.538791e-01 | 0.813 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.538791e-01 | 0.813 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.538791e-01 | 0.813 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.844965e-01 | 0.734 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.433291e-01 | 0.844 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.433291e-01 | 0.844 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.433291e-01 | 0.844 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.637911e-01 | 0.786 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.581375e-01 | 0.801 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.581375e-01 | 0.801 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.623883e-01 | 0.789 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.623883e-01 | 0.789 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.765119e-01 | 0.753 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.765119e-01 | 0.753 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.765119e-01 | 0.753 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.765119e-01 | 0.753 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 1.500954e-01 | 0.824 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.557114e-01 | 0.808 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.656570e-01 | 0.781 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.758861e-01 | 0.755 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.758861e-01 | 0.755 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.603842e-01 | 0.795 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.863873e-01 | 0.730 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.549351e-01 | 0.810 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.549351e-01 | 0.810 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.822628e-01 | 0.739 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.704941e-01 | 0.768 | 1 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.704941e-01 | 0.768 | 1 | 1 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.901028e-01 | 0.721 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.637911e-01 | 0.786 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.656570e-01 | 0.781 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.871536e-01 | 0.728 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.818315e-01 | 0.740 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 1.538791e-01 | 0.813 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.538791e-01 | 0.813 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.850529e-01 | 0.733 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.494585e-01 | 0.825 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.549351e-01 | 0.810 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.890699e-01 | 0.723 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.850529e-01 | 0.733 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.594778e-01 | 0.797 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.634886e-01 | 0.787 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.433291e-01 | 0.844 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.637911e-01 | 0.786 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.850529e-01 | 0.733 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.594778e-01 | 0.797 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.767570e-01 | 0.753 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.642660e-01 | 0.784 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.538791e-01 | 0.813 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.735782e-01 | 0.761 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.697032e-01 | 0.770 | 1 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.697032e-01 | 0.770 | 1 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.910797e-01 | 0.719 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.818315e-01 | 0.740 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.809290e-01 | 0.742 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.637911e-01 | 0.786 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.480038e-01 | 0.830 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.918927e-01 | 0.717 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 1.932766e-01 | 0.714 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 2.293127e-01 | 0.640 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.293127e-01 | 0.640 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 2.293127e-01 | 0.640 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.293127e-01 | 0.640 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 2.293127e-01 | 0.640 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.293127e-01 | 0.640 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.934121e-01 | 0.533 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 2.934121e-01 | 0.533 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 2.934121e-01 | 0.533 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 2.934121e-01 | 0.533 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 2.934121e-01 | 0.533 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 2.934121e-01 | 0.533 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.934121e-01 | 0.533 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 2.158755e-01 | 0.666 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.158755e-01 | 0.666 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 2.158755e-01 | 0.666 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 2.158755e-01 | 0.666 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.521836e-01 | 0.453 | 0 | 0 |
| Defective DPM2 causes DPM2-CDG | R-HSA-4719377 | 3.521836e-01 | 0.453 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.521836e-01 | 0.453 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.521836e-01 | 0.453 | 0 | 0 |
| Defective DPM1 causes DPM1-CDG | R-HSA-4717374 | 3.521836e-01 | 0.453 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.521836e-01 | 0.453 | 0 | 0 |
| Defective DPM3 causes DPM3-CDG | R-HSA-4719360 | 3.521836e-01 | 0.453 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.476783e-01 | 0.606 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.476783e-01 | 0.606 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.476783e-01 | 0.606 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 2.476783e-01 | 0.606 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.069836e-01 | 0.684 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.796174e-01 | 0.553 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.796174e-01 | 0.553 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.796174e-01 | 0.553 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 2.796174e-01 | 0.553 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.060700e-01 | 0.391 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.060700e-01 | 0.391 | 1 | 1 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.060700e-01 | 0.391 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.060700e-01 | 0.391 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.060700e-01 | 0.391 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.060700e-01 | 0.391 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.294566e-01 | 0.639 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.114505e-01 | 0.507 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.523509e-01 | 0.598 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.429745e-01 | 0.465 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 3.429745e-01 | 0.465 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.429745e-01 | 0.465 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.429745e-01 | 0.465 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.429745e-01 | 0.465 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.429745e-01 | 0.465 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 4.554769e-01 | 0.342 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.554769e-01 | 0.342 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.554769e-01 | 0.342 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.554769e-01 | 0.342 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 3.740208e-01 | 0.427 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.740208e-01 | 0.427 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.740208e-01 | 0.427 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.934738e-01 | 0.713 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.934738e-01 | 0.713 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.054042e-01 | 0.687 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.971484e-01 | 0.705 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.971484e-01 | 0.705 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.044508e-01 | 0.393 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.044508e-01 | 0.393 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.044508e-01 | 0.393 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.044508e-01 | 0.393 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.044508e-01 | 0.393 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.044508e-01 | 0.393 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.044508e-01 | 0.393 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.044508e-01 | 0.393 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.044508e-01 | 0.393 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.007766e-01 | 0.300 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.007766e-01 | 0.300 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.007766e-01 | 0.300 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.007766e-01 | 0.300 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.007766e-01 | 0.300 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.007766e-01 | 0.300 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.007766e-01 | 0.300 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.007766e-01 | 0.300 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.857206e-01 | 0.544 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.427447e-01 | 0.615 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.023437e-01 | 0.519 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 4.341523e-01 | 0.362 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.687416e-01 | 0.571 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.543890e-01 | 0.595 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.088745e-01 | 0.680 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.820128e-01 | 0.550 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.293974e-01 | 0.482 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.156798e-01 | 0.381 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.630362e-01 | 0.334 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.630362e-01 | 0.334 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.630362e-01 | 0.334 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.423102e-01 | 0.266 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.423102e-01 | 0.266 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.423102e-01 | 0.266 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.423102e-01 | 0.266 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.423102e-01 | 0.266 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.423102e-01 | 0.266 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.423102e-01 | 0.266 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.868809e-01 | 0.412 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.868809e-01 | 0.412 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.195217e-01 | 0.377 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 4.910328e-01 | 0.309 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.910328e-01 | 0.309 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.910328e-01 | 0.309 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.910328e-01 | 0.309 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.038345e-01 | 0.394 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 2.518577e-01 | 0.599 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.543279e-01 | 0.451 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.451566e-01 | 0.462 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.608300e-01 | 0.336 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.608300e-01 | 0.336 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.375394e-01 | 0.359 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.575804e-01 | 0.340 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.803906e-01 | 0.236 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 5.803906e-01 | 0.236 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.803906e-01 | 0.236 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 5.803906e-01 | 0.236 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 5.803906e-01 | 0.236 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.803906e-01 | 0.236 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.200690e-01 | 0.377 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.200690e-01 | 0.377 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.616912e-01 | 0.336 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.129354e-01 | 0.290 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.033973e-01 | 0.298 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.549826e-01 | 0.342 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.692930e-01 | 0.329 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.308083e-01 | 0.275 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.460866e-01 | 0.263 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.460866e-01 | 0.263 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.460866e-01 | 0.263 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.692492e-01 | 0.245 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.554478e-01 | 0.255 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.919318e-01 | 0.407 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.129354e-01 | 0.290 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.549826e-01 | 0.342 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.621314e-01 | 0.250 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.483516e-01 | 0.261 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.868809e-01 | 0.412 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.808658e-01 | 0.419 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.160294e-01 | 0.287 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.060552e-01 | 0.686 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.007778e-01 | 0.300 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.056441e-01 | 0.392 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.592057e-01 | 0.445 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.868809e-01 | 0.412 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 5.803906e-01 | 0.236 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.424590e-01 | 0.266 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.910328e-01 | 0.309 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.801563e-01 | 0.420 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.460866e-01 | 0.263 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.796174e-01 | 0.553 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.608300e-01 | 0.336 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.158755e-01 | 0.666 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.114505e-01 | 0.507 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.698994e-01 | 0.432 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.384280e-01 | 0.358 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.692492e-01 | 0.245 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.642182e-01 | 0.439 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.762945e-01 | 0.322 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.226808e-01 | 0.491 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.530501e-01 | 0.597 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.740208e-01 | 0.427 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.044508e-01 | 0.393 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.044508e-01 | 0.393 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.044508e-01 | 0.393 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.556457e-01 | 0.592 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 4.910328e-01 | 0.309 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.803906e-01 | 0.236 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.214008e-01 | 0.655 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.459520e-01 | 0.461 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.210356e-01 | 0.283 | 1 | 1 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.459520e-01 | 0.461 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.156798e-01 | 0.381 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.868809e-01 | 0.412 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.868809e-01 | 0.412 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.461138e-01 | 0.609 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.707923e-01 | 0.327 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.205377e-01 | 0.494 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.796174e-01 | 0.553 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.429745e-01 | 0.465 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.554769e-01 | 0.342 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 4.554769e-01 | 0.342 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.393719e-01 | 0.621 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.803906e-01 | 0.236 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.044054e-01 | 0.297 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.692930e-01 | 0.329 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.754285e-01 | 0.323 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.960048e-01 | 0.708 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.254911e-01 | 0.279 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.702328e-01 | 0.244 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.705918e-01 | 0.431 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.031485e-01 | 0.518 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.744294e-01 | 0.562 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.060700e-01 | 0.391 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.060700e-01 | 0.391 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.989511e-01 | 0.524 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.225075e-01 | 0.491 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.009742e-01 | 0.521 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.803906e-01 | 0.236 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.659900e-01 | 0.332 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.321591e-01 | 0.634 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.740208e-01 | 0.427 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.459520e-01 | 0.461 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.425296e-01 | 0.615 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.425296e-01 | 0.615 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.425296e-01 | 0.615 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.425296e-01 | 0.615 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.423102e-01 | 0.266 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.825562e-01 | 0.316 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.189150e-01 | 0.285 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.530501e-01 | 0.597 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.128692e-01 | 0.290 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.828368e-01 | 0.316 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.648671e-01 | 0.577 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 2.796174e-01 | 0.553 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.648938e-01 | 0.577 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.176513e-01 | 0.662 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.555310e-01 | 0.593 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.910328e-01 | 0.309 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.274769e-01 | 0.643 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.308913e-01 | 0.480 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.023437e-01 | 0.519 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.554497e-01 | 0.255 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.428248e-01 | 0.354 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.293127e-01 | 0.640 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.293127e-01 | 0.640 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.521836e-01 | 0.453 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.521836e-01 | 0.453 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.521836e-01 | 0.453 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.069836e-01 | 0.684 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.755517e-01 | 0.560 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.554769e-01 | 0.342 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.554769e-01 | 0.342 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.648938e-01 | 0.577 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.740208e-01 | 0.427 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.740208e-01 | 0.427 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.044508e-01 | 0.393 | 0 | 0 |
| Synthesis of dolichyl-phosphate mannose | R-HSA-162699 | 5.007766e-01 | 0.300 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.308614e-01 | 0.637 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.921376e-01 | 0.407 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.375394e-01 | 0.359 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.707923e-01 | 0.327 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.129354e-01 | 0.290 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 5.692492e-01 | 0.245 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.682722e-01 | 0.245 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.801563e-01 | 0.420 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.672227e-01 | 0.435 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.784933e-01 | 0.320 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.668240e-01 | 0.574 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.207221e-01 | 0.376 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.384936e-01 | 0.623 | 1 | 0 |
| G2/M Transition | R-HSA-69275 | 2.521880e-01 | 0.598 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.232893e-01 | 0.281 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 3.031485e-01 | 0.518 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.922497e-01 | 0.534 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.832881e-01 | 0.316 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 4.554769e-01 | 0.342 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.746391e-01 | 0.426 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.637025e-01 | 0.249 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.114505e-01 | 0.507 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.926413e-01 | 0.406 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.441704e-01 | 0.264 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.692492e-01 | 0.245 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.129354e-01 | 0.290 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 4.002486e-01 | 0.398 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.531779e-01 | 0.452 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.056441e-01 | 0.392 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.707923e-01 | 0.327 | 1 | 1 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.069836e-01 | 0.684 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.060700e-01 | 0.391 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.276455e-01 | 0.643 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.044508e-01 | 0.393 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.044508e-01 | 0.393 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.044508e-01 | 0.393 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.007766e-01 | 0.300 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.803906e-01 | 0.236 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.039197e-01 | 0.394 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.038345e-01 | 0.394 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.762945e-01 | 0.322 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.441704e-01 | 0.264 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.299397e-01 | 0.367 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.044508e-01 | 0.393 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.156798e-01 | 0.381 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.386447e-01 | 0.358 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.308083e-01 | 0.275 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.023437e-01 | 0.519 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.307212e-01 | 0.481 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 2.293127e-01 | 0.640 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.293127e-01 | 0.640 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.293127e-01 | 0.640 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 2.934121e-01 | 0.533 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.521836e-01 | 0.453 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.523509e-01 | 0.598 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 4.554769e-01 | 0.342 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.461138e-01 | 0.609 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.007766e-01 | 0.300 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.630362e-01 | 0.334 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.441704e-01 | 0.264 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.460866e-01 | 0.263 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.614167e-01 | 0.442 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.002486e-01 | 0.398 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.425296e-01 | 0.615 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.634638e-01 | 0.579 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.971484e-01 | 0.705 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.743920e-01 | 0.241 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.446037e-01 | 0.352 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.294566e-01 | 0.639 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.429745e-01 | 0.465 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.060552e-01 | 0.686 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.224489e-01 | 0.492 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.693754e-01 | 0.433 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.630362e-01 | 0.334 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.061106e-01 | 0.391 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.441704e-01 | 0.264 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.420629e-01 | 0.355 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.564955e-01 | 0.255 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.294566e-01 | 0.639 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.749907e-01 | 0.426 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.699708e-01 | 0.569 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.190449e-01 | 0.378 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.698994e-01 | 0.432 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 2.934121e-01 | 0.533 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.158755e-01 | 0.666 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 3.521836e-01 | 0.453 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.796174e-01 | 0.553 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.060700e-01 | 0.391 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.523509e-01 | 0.598 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.095508e-01 | 0.679 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.095508e-01 | 0.679 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.007766e-01 | 0.300 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.693754e-01 | 0.433 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.910328e-01 | 0.309 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.672227e-01 | 0.435 | 1 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.386447e-01 | 0.358 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.180900e-01 | 0.286 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.180900e-01 | 0.286 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.803906e-01 | 0.236 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.803906e-01 | 0.236 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 5.441704e-01 | 0.264 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.460866e-01 | 0.263 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.926413e-01 | 0.406 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.044054e-01 | 0.297 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.254991e-01 | 0.279 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.184768e-01 | 0.285 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.910328e-01 | 0.309 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.796174e-01 | 0.553 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.634638e-01 | 0.579 | 1 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 2.934121e-01 | 0.533 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.476783e-01 | 0.606 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.554769e-01 | 0.342 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.989511e-01 | 0.524 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.740208e-01 | 0.427 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.341523e-01 | 0.362 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.803906e-01 | 0.236 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.177964e-01 | 0.379 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.528254e-01 | 0.597 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.692492e-01 | 0.245 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.226808e-01 | 0.491 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.868809e-01 | 0.412 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 2.069836e-01 | 0.684 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.429745e-01 | 0.465 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.044054e-01 | 0.297 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.293974e-01 | 0.482 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.730177e-01 | 0.564 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.031485e-01 | 0.518 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.423102e-01 | 0.266 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.608300e-01 | 0.336 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.971484e-01 | 0.705 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.114505e-01 | 0.507 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 4.747110e-01 | 0.324 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.531052e-01 | 0.257 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.959934e-01 | 0.305 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.774963e-01 | 0.238 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.044054e-01 | 0.297 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.806826e-01 | 0.236 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.809226e-01 | 0.236 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.809226e-01 | 0.236 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.823716e-01 | 0.235 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.823716e-01 | 0.235 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.823716e-01 | 0.235 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.856440e-01 | 0.232 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.856440e-01 | 0.232 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.856440e-01 | 0.232 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.856440e-01 | 0.232 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.933125e-01 | 0.227 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 5.933125e-01 | 0.227 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.933125e-01 | 0.227 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.933125e-01 | 0.227 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.933125e-01 | 0.227 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.933125e-01 | 0.227 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.933905e-01 | 0.227 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.957560e-01 | 0.225 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.978534e-01 | 0.223 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.988156e-01 | 0.223 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 5.988156e-01 | 0.223 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.988156e-01 | 0.223 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.046932e-01 | 0.218 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.101935e-01 | 0.215 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.101935e-01 | 0.215 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.111869e-01 | 0.214 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.140029e-01 | 0.212 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.148645e-01 | 0.211 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.148645e-01 | 0.211 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.148645e-01 | 0.211 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.148645e-01 | 0.211 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.149317e-01 | 0.211 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 6.153047e-01 | 0.211 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.153047e-01 | 0.211 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 6.153047e-01 | 0.211 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.153047e-01 | 0.211 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.153047e-01 | 0.211 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.153047e-01 | 0.211 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.153047e-01 | 0.211 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.163557e-01 | 0.210 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.163557e-01 | 0.210 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.177473e-01 | 0.209 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.229255e-01 | 0.206 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.235614e-01 | 0.205 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.381491e-01 | 0.195 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.381780e-01 | 0.195 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.383820e-01 | 0.195 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.383820e-01 | 0.195 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.383820e-01 | 0.195 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.383820e-01 | 0.195 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.383820e-01 | 0.195 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.383820e-01 | 0.195 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.383820e-01 | 0.195 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.406835e-01 | 0.193 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.406835e-01 | 0.193 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.406835e-01 | 0.193 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.440200e-01 | 0.191 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.457370e-01 | 0.190 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 6.457370e-01 | 0.190 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.473157e-01 | 0.189 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.473157e-01 | 0.189 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.473157e-01 | 0.189 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.473157e-01 | 0.189 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.473157e-01 | 0.189 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.473157e-01 | 0.189 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.473157e-01 | 0.189 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 6.473157e-01 | 0.189 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.473157e-01 | 0.189 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.473157e-01 | 0.189 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.473157e-01 | 0.189 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.473157e-01 | 0.189 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.476573e-01 | 0.189 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.479238e-01 | 0.188 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.489790e-01 | 0.188 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.594010e-01 | 0.181 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.594010e-01 | 0.181 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.594010e-01 | 0.181 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.594010e-01 | 0.181 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 6.605454e-01 | 0.180 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.661628e-01 | 0.176 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.697687e-01 | 0.174 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.697687e-01 | 0.174 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.744062e-01 | 0.171 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.744062e-01 | 0.171 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.749285e-01 | 0.171 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.749285e-01 | 0.171 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 6.749285e-01 | 0.171 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.749285e-01 | 0.171 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.749675e-01 | 0.171 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.759124e-01 | 0.170 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.766647e-01 | 0.170 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.766647e-01 | 0.170 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.766647e-01 | 0.170 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.766647e-01 | 0.170 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.766647e-01 | 0.170 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.766647e-01 | 0.170 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 6.766647e-01 | 0.170 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.766647e-01 | 0.170 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 6.766647e-01 | 0.170 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.766647e-01 | 0.170 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 6.766647e-01 | 0.170 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 6.766647e-01 | 0.170 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.766647e-01 | 0.170 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.766647e-01 | 0.170 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.766647e-01 | 0.170 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.766647e-01 | 0.170 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.766647e-01 | 0.170 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.794278e-01 | 0.168 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.794278e-01 | 0.168 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.794278e-01 | 0.168 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.794278e-01 | 0.168 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.814597e-01 | 0.167 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.843397e-01 | 0.165 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 6.901946e-01 | 0.161 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.901946e-01 | 0.161 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.903690e-01 | 0.161 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.903690e-01 | 0.161 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.903690e-01 | 0.161 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.903690e-01 | 0.161 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 6.903690e-01 | 0.161 | 1 | 1 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.984820e-01 | 0.156 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.984820e-01 | 0.156 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.984820e-01 | 0.156 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.984820e-01 | 0.156 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.984820e-01 | 0.156 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.984820e-01 | 0.156 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.984820e-01 | 0.156 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.984820e-01 | 0.156 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.023750e-01 | 0.153 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.024076e-01 | 0.153 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.035730e-01 | 0.153 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.035730e-01 | 0.153 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.035730e-01 | 0.153 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.035730e-01 | 0.153 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.035730e-01 | 0.153 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.035730e-01 | 0.153 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.057355e-01 | 0.151 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.057355e-01 | 0.151 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.057355e-01 | 0.151 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.087041e-01 | 0.150 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.087041e-01 | 0.150 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.087041e-01 | 0.150 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.097184e-01 | 0.149 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.131561e-01 | 0.147 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.131908e-01 | 0.147 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.131908e-01 | 0.147 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.155021e-01 | 0.145 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.165605e-01 | 0.145 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.165866e-01 | 0.145 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.165866e-01 | 0.145 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.166765e-01 | 0.145 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 7.191382e-01 | 0.143 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.205110e-01 | 0.142 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.205110e-01 | 0.142 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.205110e-01 | 0.142 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.205110e-01 | 0.142 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.257247e-01 | 0.139 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.281679e-01 | 0.138 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.281679e-01 | 0.138 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.281679e-01 | 0.138 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 7.282435e-01 | 0.138 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.282435e-01 | 0.138 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.282435e-01 | 0.138 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.282435e-01 | 0.138 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.282435e-01 | 0.138 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.283523e-01 | 0.138 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.283523e-01 | 0.138 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.283523e-01 | 0.138 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.318476e-01 | 0.136 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.337678e-01 | 0.134 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.337678e-01 | 0.134 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.337678e-01 | 0.134 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.347022e-01 | 0.134 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 7.347022e-01 | 0.134 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 7.347022e-01 | 0.134 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.362760e-01 | 0.133 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.475074e-01 | 0.126 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.475074e-01 | 0.126 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.477267e-01 | 0.126 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.493162e-01 | 0.125 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.500538e-01 | 0.125 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.508620e-01 | 0.124 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.508620e-01 | 0.124 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.508620e-01 | 0.124 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.508620e-01 | 0.124 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.508620e-01 | 0.124 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.508620e-01 | 0.124 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.508620e-01 | 0.124 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.508620e-01 | 0.124 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.508620e-01 | 0.124 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.508620e-01 | 0.124 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.522240e-01 | 0.124 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 7.522240e-01 | 0.124 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.547526e-01 | 0.122 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.551223e-01 | 0.122 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.613679e-01 | 0.118 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.613679e-01 | 0.118 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.613679e-01 | 0.118 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.636225e-01 | 0.117 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.654746e-01 | 0.116 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.654746e-01 | 0.116 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.654746e-01 | 0.116 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.715993e-01 | 0.113 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.715993e-01 | 0.113 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.715993e-01 | 0.113 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.715993e-01 | 0.113 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.715993e-01 | 0.113 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 7.715993e-01 | 0.113 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.715993e-01 | 0.113 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.715993e-01 | 0.113 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.715993e-01 | 0.113 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.715993e-01 | 0.113 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.738638e-01 | 0.111 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.738638e-01 | 0.111 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.746081e-01 | 0.111 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.800613e-01 | 0.108 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.805798e-01 | 0.108 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 7.858180e-01 | 0.105 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.858180e-01 | 0.105 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.858180e-01 | 0.105 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.875951e-01 | 0.104 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.876284e-01 | 0.104 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 7.906116e-01 | 0.102 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.906116e-01 | 0.102 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.906116e-01 | 0.102 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.906116e-01 | 0.102 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 7.906116e-01 | 0.102 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.906116e-01 | 0.102 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.906116e-01 | 0.102 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.906116e-01 | 0.102 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 7.906116e-01 | 0.102 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.906116e-01 | 0.102 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.933403e-01 | 0.101 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.938459e-01 | 0.100 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.938459e-01 | 0.100 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 7.938459e-01 | 0.100 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.938459e-01 | 0.100 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.938459e-01 | 0.100 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.955203e-01 | 0.099 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.972437e-01 | 0.098 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.972437e-01 | 0.098 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.019807e-01 | 0.096 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.051540e-01 | 0.094 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.058156e-01 | 0.094 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.058156e-01 | 0.094 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.068609e-01 | 0.093 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.068609e-01 | 0.093 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.068609e-01 | 0.093 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.068609e-01 | 0.093 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.068609e-01 | 0.093 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.074029e-01 | 0.093 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.074029e-01 | 0.093 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.080423e-01 | 0.093 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.080423e-01 | 0.093 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.080423e-01 | 0.093 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.080423e-01 | 0.093 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.080423e-01 | 0.093 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.080423e-01 | 0.093 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.080423e-01 | 0.093 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.080423e-01 | 0.093 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.080423e-01 | 0.093 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.080423e-01 | 0.093 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.080423e-01 | 0.093 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.081549e-01 | 0.093 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.081549e-01 | 0.093 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.119467e-01 | 0.090 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.119467e-01 | 0.090 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.128611e-01 | 0.090 | 1 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.140753e-01 | 0.089 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.140753e-01 | 0.089 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.145572e-01 | 0.089 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.145572e-01 | 0.089 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.161028e-01 | 0.088 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.161028e-01 | 0.088 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.162325e-01 | 0.088 | 1 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.185663e-01 | 0.087 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.191387e-01 | 0.087 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.191387e-01 | 0.087 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.191387e-01 | 0.087 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.191387e-01 | 0.087 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.192216e-01 | 0.087 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.228681e-01 | 0.085 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.230492e-01 | 0.085 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.238431e-01 | 0.084 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.240229e-01 | 0.084 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.240229e-01 | 0.084 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.240229e-01 | 0.084 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.240229e-01 | 0.084 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.240229e-01 | 0.084 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.240229e-01 | 0.084 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.240229e-01 | 0.084 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.240229e-01 | 0.084 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.240229e-01 | 0.084 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.240229e-01 | 0.084 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.240229e-01 | 0.084 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.240229e-01 | 0.084 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.262752e-01 | 0.083 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.284929e-01 | 0.082 | 1 | 1 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.284929e-01 | 0.082 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.293241e-01 | 0.081 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.307119e-01 | 0.081 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.307119e-01 | 0.081 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.307119e-01 | 0.081 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.322458e-01 | 0.080 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.330405e-01 | 0.079 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.330405e-01 | 0.079 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.379500e-01 | 0.077 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.379500e-01 | 0.077 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.379500e-01 | 0.077 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.379500e-01 | 0.077 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 8.386740e-01 | 0.076 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.386740e-01 | 0.076 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.386740e-01 | 0.076 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.386740e-01 | 0.076 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.386740e-01 | 0.076 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.386740e-01 | 0.076 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.386740e-01 | 0.076 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.386740e-01 | 0.076 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.398101e-01 | 0.076 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.405493e-01 | 0.075 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.456535e-01 | 0.073 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.456535e-01 | 0.073 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.461411e-01 | 0.073 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.469534e-01 | 0.072 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.469534e-01 | 0.072 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.480133e-01 | 0.072 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.485048e-01 | 0.071 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 8.485048e-01 | 0.071 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.518729e-01 | 0.070 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.518729e-01 | 0.070 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.518729e-01 | 0.070 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.518729e-01 | 0.070 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.518729e-01 | 0.070 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.521062e-01 | 0.070 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.521062e-01 | 0.070 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.521062e-01 | 0.070 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.521062e-01 | 0.070 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.521062e-01 | 0.070 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.521062e-01 | 0.070 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.521062e-01 | 0.070 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.521062e-01 | 0.070 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.521062e-01 | 0.070 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 8.526565e-01 | 0.069 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.537633e-01 | 0.069 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.538344e-01 | 0.069 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.538344e-01 | 0.069 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.555187e-01 | 0.068 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.561219e-01 | 0.067 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.581972e-01 | 0.066 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.615233e-01 | 0.065 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.615233e-01 | 0.065 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.615233e-01 | 0.065 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.615233e-01 | 0.065 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.615233e-01 | 0.065 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.634106e-01 | 0.064 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.634106e-01 | 0.064 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.634988e-01 | 0.064 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.634988e-01 | 0.064 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.636617e-01 | 0.064 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.644206e-01 | 0.063 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.644206e-01 | 0.063 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.644206e-01 | 0.063 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.644206e-01 | 0.063 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 8.644206e-01 | 0.063 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 8.644206e-01 | 0.063 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.644206e-01 | 0.063 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.644206e-01 | 0.063 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.644206e-01 | 0.063 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.644206e-01 | 0.063 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 8.644206e-01 | 0.063 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.644206e-01 | 0.063 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 8.644206e-01 | 0.063 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.644206e-01 | 0.063 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 8.644206e-01 | 0.063 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.649390e-01 | 0.063 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.661397e-01 | 0.062 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.697419e-01 | 0.061 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.703017e-01 | 0.060 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.703807e-01 | 0.060 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.705946e-01 | 0.060 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.705946e-01 | 0.060 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.705946e-01 | 0.060 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.705946e-01 | 0.060 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.705946e-01 | 0.060 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.713982e-01 | 0.060 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.713982e-01 | 0.060 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 8.724390e-01 | 0.059 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.745299e-01 | 0.058 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.757104e-01 | 0.058 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.757104e-01 | 0.058 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.757104e-01 | 0.058 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.757104e-01 | 0.058 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.757104e-01 | 0.058 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.757104e-01 | 0.058 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.757104e-01 | 0.058 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.757104e-01 | 0.058 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.757104e-01 | 0.058 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.757104e-01 | 0.058 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.760236e-01 | 0.057 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.770422e-01 | 0.057 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.787438e-01 | 0.056 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.787438e-01 | 0.056 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.803756e-01 | 0.055 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.807752e-01 | 0.055 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 8.860607e-01 | 0.053 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 8.860607e-01 | 0.053 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 8.860607e-01 | 0.053 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 8.860607e-01 | 0.053 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.860607e-01 | 0.053 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.860607e-01 | 0.053 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.860607e-01 | 0.053 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.860607e-01 | 0.053 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.863781e-01 | 0.052 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.871164e-01 | 0.052 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.871164e-01 | 0.052 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.894792e-01 | 0.051 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.894792e-01 | 0.051 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.902761e-01 | 0.050 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.919315e-01 | 0.050 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.923241e-01 | 0.049 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.923241e-01 | 0.049 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.923241e-01 | 0.049 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.923241e-01 | 0.049 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.946233e-01 | 0.048 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.946233e-01 | 0.048 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 8.946233e-01 | 0.048 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.955496e-01 | 0.048 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 8.955496e-01 | 0.048 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.955496e-01 | 0.048 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.955496e-01 | 0.048 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.955496e-01 | 0.048 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.955496e-01 | 0.048 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 8.955496e-01 | 0.048 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.957863e-01 | 0.048 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.015431e-01 | 0.045 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.016634e-01 | 0.045 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.016634e-01 | 0.045 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.038275e-01 | 0.044 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.038275e-01 | 0.044 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.042488e-01 | 0.044 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.042488e-01 | 0.044 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.042488e-01 | 0.044 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.042488e-01 | 0.044 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.042488e-01 | 0.044 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.042488e-01 | 0.044 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.042488e-01 | 0.044 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.042488e-01 | 0.044 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.042488e-01 | 0.044 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.042488e-01 | 0.044 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.045238e-01 | 0.044 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.060734e-01 | 0.043 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.082624e-01 | 0.042 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.082624e-01 | 0.042 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.082624e-01 | 0.042 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.098335e-01 | 0.041 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.099656e-01 | 0.041 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.122240e-01 | 0.040 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.122240e-01 | 0.040 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.122240e-01 | 0.040 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.122240e-01 | 0.040 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.122240e-01 | 0.040 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.135204e-01 | 0.039 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.144448e-01 | 0.039 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.144448e-01 | 0.039 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.144448e-01 | 0.039 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.149220e-01 | 0.039 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.154594e-01 | 0.038 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.195353e-01 | 0.036 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.195353e-01 | 0.036 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.195353e-01 | 0.036 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.195353e-01 | 0.036 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.195353e-01 | 0.036 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.195353e-01 | 0.036 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.202344e-01 | 0.036 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.204123e-01 | 0.036 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.226882e-01 | 0.035 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.226882e-01 | 0.035 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 9.247379e-01 | 0.034 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.247658e-01 | 0.034 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.252420e-01 | 0.034 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.256536e-01 | 0.034 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.262381e-01 | 0.033 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.262381e-01 | 0.033 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 9.262381e-01 | 0.033 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.262381e-01 | 0.033 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 9.262381e-01 | 0.033 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 9.262381e-01 | 0.033 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.265933e-01 | 0.033 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.303219e-01 | 0.031 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.307238e-01 | 0.031 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 9.323828e-01 | 0.030 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 9.323828e-01 | 0.030 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.323828e-01 | 0.030 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.323828e-01 | 0.030 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.323828e-01 | 0.030 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.323828e-01 | 0.030 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.323828e-01 | 0.030 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.323828e-01 | 0.030 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.323828e-01 | 0.030 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.338807e-01 | 0.030 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.339764e-01 | 0.030 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.354657e-01 | 0.029 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.354657e-01 | 0.029 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.354657e-01 | 0.029 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.365955e-01 | 0.028 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.380161e-01 | 0.028 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.380161e-01 | 0.028 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.380161e-01 | 0.028 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.380161e-01 | 0.028 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.380161e-01 | 0.028 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.380161e-01 | 0.028 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.390680e-01 | 0.027 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.397093e-01 | 0.027 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.398987e-01 | 0.027 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.398987e-01 | 0.027 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.399995e-01 | 0.027 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.399995e-01 | 0.027 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.417608e-01 | 0.026 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.417608e-01 | 0.026 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.431803e-01 | 0.025 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.431803e-01 | 0.025 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.431803e-01 | 0.025 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.431803e-01 | 0.025 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.431803e-01 | 0.025 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.431803e-01 | 0.025 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.431803e-01 | 0.025 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.431803e-01 | 0.025 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.431803e-01 | 0.025 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.431803e-01 | 0.025 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.431803e-01 | 0.025 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.431803e-01 | 0.025 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.431803e-01 | 0.025 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.440414e-01 | 0.025 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.440414e-01 | 0.025 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.449285e-01 | 0.025 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.465223e-01 | 0.024 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.465419e-01 | 0.024 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.477809e-01 | 0.023 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.479145e-01 | 0.023 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.479145e-01 | 0.023 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.479145e-01 | 0.023 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.479145e-01 | 0.023 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.479145e-01 | 0.023 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.479145e-01 | 0.023 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.481407e-01 | 0.023 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.486868e-01 | 0.023 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 9.495342e-01 | 0.022 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.495342e-01 | 0.022 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.515252e-01 | 0.022 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.515252e-01 | 0.022 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.515252e-01 | 0.022 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.519649e-01 | 0.021 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.520116e-01 | 0.021 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 9.522545e-01 | 0.021 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.522545e-01 | 0.021 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.522545e-01 | 0.021 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.522545e-01 | 0.021 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.522545e-01 | 0.021 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.562332e-01 | 0.019 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.562332e-01 | 0.019 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.562332e-01 | 0.019 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.564069e-01 | 0.019 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.583648e-01 | 0.018 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.592657e-01 | 0.018 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.598805e-01 | 0.018 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.598805e-01 | 0.018 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.602956e-01 | 0.018 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.632241e-01 | 0.016 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.632241e-01 | 0.016 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.635284e-01 | 0.016 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.643846e-01 | 0.016 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.651283e-01 | 0.015 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.654365e-01 | 0.015 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.655022e-01 | 0.015 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.655022e-01 | 0.015 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.662891e-01 | 0.015 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.662891e-01 | 0.015 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.662891e-01 | 0.015 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.662891e-01 | 0.015 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.662891e-01 | 0.015 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.662891e-01 | 0.015 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.666181e-01 | 0.015 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.673313e-01 | 0.014 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.673313e-01 | 0.014 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.673772e-01 | 0.014 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.686570e-01 | 0.014 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.686570e-01 | 0.014 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.690989e-01 | 0.014 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.690989e-01 | 0.014 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.691577e-01 | 0.014 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.699712e-01 | 0.013 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.703733e-01 | 0.013 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.707963e-01 | 0.013 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.708750e-01 | 0.013 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.716747e-01 | 0.012 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.716747e-01 | 0.012 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.716747e-01 | 0.012 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.716747e-01 | 0.012 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.716747e-01 | 0.012 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.716747e-01 | 0.012 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.721420e-01 | 0.012 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.731778e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.740359e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.740359e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.740359e-01 | 0.011 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.740359e-01 | 0.011 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 9.740359e-01 | 0.011 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.740359e-01 | 0.011 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.748654e-01 | 0.011 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.748654e-01 | 0.011 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.748955e-01 | 0.011 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.753363e-01 | 0.011 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.762004e-01 | 0.010 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.762004e-01 | 0.010 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.762004e-01 | 0.010 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.766570e-01 | 0.010 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.768007e-01 | 0.010 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.773211e-01 | 0.010 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.780223e-01 | 0.010 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.781833e-01 | 0.010 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.781846e-01 | 0.010 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.781846e-01 | 0.010 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.781846e-01 | 0.010 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.783248e-01 | 0.010 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.800034e-01 | 0.009 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.800034e-01 | 0.009 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.800034e-01 | 0.009 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.800034e-01 | 0.009 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.800034e-01 | 0.009 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.804760e-01 | 0.009 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.807190e-01 | 0.008 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.813209e-01 | 0.008 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.816707e-01 | 0.008 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.826641e-01 | 0.008 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.826641e-01 | 0.008 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.831991e-01 | 0.007 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.831991e-01 | 0.007 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.846001e-01 | 0.007 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.846001e-01 | 0.007 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.846001e-01 | 0.007 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.849784e-01 | 0.007 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.853268e-01 | 0.006 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.854313e-01 | 0.006 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.855633e-01 | 0.006 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.858844e-01 | 0.006 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.858844e-01 | 0.006 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.858844e-01 | 0.006 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.861547e-01 | 0.006 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.868808e-01 | 0.006 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.870616e-01 | 0.006 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.870616e-01 | 0.006 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.871582e-01 | 0.006 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.889572e-01 | 0.005 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.891299e-01 | 0.005 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.891299e-01 | 0.005 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.891299e-01 | 0.005 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.895758e-01 | 0.005 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.895758e-01 | 0.005 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.897620e-01 | 0.004 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.900367e-01 | 0.004 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.900367e-01 | 0.004 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.908678e-01 | 0.004 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.908678e-01 | 0.004 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.915310e-01 | 0.004 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.918478e-01 | 0.004 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.922206e-01 | 0.003 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.923280e-01 | 0.003 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.923280e-01 | 0.003 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.930010e-01 | 0.003 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.930010e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.931230e-01 | 0.003 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.931230e-01 | 0.003 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.940210e-01 | 0.003 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.940926e-01 | 0.003 | 1 | 1 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.942663e-01 | 0.002 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.944374e-01 | 0.002 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.950375e-01 | 0.002 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.951166e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.952299e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.952299e-01 | 0.002 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.958313e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.958759e-01 | 0.002 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.959114e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.959515e-01 | 0.002 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.961792e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.964982e-01 | 0.002 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.964982e-01 | 0.002 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.970584e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.973040e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.973040e-01 | 0.001 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.973040e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.975291e-01 | 0.001 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.975845e-01 | 0.001 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.979245e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.983419e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.984023e-01 | 0.001 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.984515e-01 | 0.001 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.984515e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.985358e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.986581e-01 | 0.001 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.987715e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.988054e-01 | 0.001 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.988792e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.990534e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.990727e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.990727e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.991418e-01 | 0.000 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.991922e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.992050e-01 | 0.000 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.992082e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.992684e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.992714e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.993237e-01 | 0.000 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.993364e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.993608e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.993628e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.994815e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.994881e-01 | 0.000 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.995079e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.995455e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.995568e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.997183e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.997399e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.997444e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.997444e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.998246e-01 | 0.000 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.998292e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998729e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999283e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999327e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999389e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999576e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999694e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999788e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999869e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999893e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999930e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999932e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999945e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999954e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999965e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999972e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999973e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999989e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999994e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999994e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999996e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999997e-01 | 0.000 | 1 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999998e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999999e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999999e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999999e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.000000e+00 | 0.000 | 1 | 1 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.000000e+00 | 0.000 | 1 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.000000e+00 | 0.000 | 1 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 1.000000e+00 | 0.000 | 1 | 1 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.000000e+00 | 0.000 | 1 | 1 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.000000e+00 | 0.000 | 1 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 1.000000e+00 | 0.000 | 1 | 1 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.000000e+00 | 0.000 | 1 | 1 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.000000e+00 | 0.000 | 1 | 0 |